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ABSTRACT 
 Endocytosis is the process by which cells internalize extracellular and 
transmembrane cargo from their environment. The process requires dozens of proteins to 
be recruited in a specific order to the site of endocytosis on the plasma membrane. These 
proteins bind the cargo to be internalized, form a coat on the membrane, deform the 
membrane using the force of actin polymerization to create the nascent vesicle, and 
finally pinch off the vesicle to allow for the cargo to be trafficked within the cell. 
Clathrin-mediated endocytosis (CME) is the most studied endocytic mechanism; both the 
order of events and the proteins involved are well conserved in eukaryotic organisms. 
Due to quick reproduction times and ease of genetic manipulations, Saccharomyces 
cerevisiae is an ideal model system to gain insight into the precise mechanisms that are 
required to coordinate CME.  
 The timeline of CME is separated into four steps based on the proteins that are 
recruited during that stage: early coat, late coat, actin polymerization, and 
scission/uncoating. Although much is known about what proteins are recruited and when, 
there are still open questions concerning how each stage transitions to the next. The 
scaffold protein Intersectin/Pan1 may function as a coordinator between endocytic stages 
due to its multiple interactions with several proteins in the early, late, and actin 
polymerization stages. Intersectin and Pan1 are essential for life, making research of their 
function technically difficult. In this dissertation, a degron allele of Pan1 (Pan1-AID) was 
constructed to acutely deplete cells of Pan1 protein and observe the resulting phenotypes 
in vivo. Using Pan1-AID, it was discovered that Pan1 is critical for strengthening 
interactions during three transitions in CME: early coat to late coat, actin regulators to 
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actin machinery, and coat/actin machinery to the plasma membrane. In addition, the 
regions and domains that are critical for Pan1’s endocytic and essential functions have 
been defined. Portions of Pan1 were found that can support viability, but not endocytosis, 
suggesting that these functions can be separated and Pan1, like Intersectin, may have 
additional roles in the cell.  
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Discovery of endocytosis 
 Eukaryotic cells are surrounded by a lipid bilayer called a plasma membrane; this 
thin, flexible, dynamic membrane is what separates the extracellular from the 
intracellular environment of the cell. The surface of the plasma membrane must protect 
the cell from environmental stressors, relay informational signals, and selectively choose 
what extracellular matter to allow passage into the cell and when. The simple act of cargo 
internalization by the plasma membrane has evolved into an incredibly diverse, highly 
regulated, complex set of pathways collectively called endocytosis. Endocytosis is critical 
for several cellular homeostatic functions including nutrient uptake, signal transduction, 
regulation of membrane composition, cell adhesion and migration, and cell polarity. 
Pathogens, such as bacteria and viruses, have evolved ways hijack a host cell’s endocytic 
machinery in order to induce their own internalization into the cytoplasm. Through 
careful observation, researchers have learned from pathogens how to use endogenous 
endocytic routes to induce the proper uptake and trafficking of therapeutics to specific 
organelles. Over the past 80 years, the various endocytic mechanisms have been 
meticulously characterized, yet there are still many remaining open questions.  
 Membrane internalization was first visualized in the 1930s from movies of 
phagocytic cells, but it wasn’t until the development of electron microscopy that 
endocytosis was truly described in the 1960s by Thomas Roth and Keith Porter (Roth & 
Porter, 1964). Their careful observations of electron micrographs of yolk uptake by 
mosquito oocytes found that vesicles containing yolk were created at curved, dense 
regions of the plasma membrane. These regions deformed into vesicles that were 
surrounded by a “bristle coat” which fell off after vesicle scission, but before the 
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internalized vesicles fused together. Just a decade later, biochemical studies led to the 
discovery that this bristle coat was made of a protein called clathrin (Pearse et al., 1975; 
Crowther et al., 1976). Around the same time, electron microscopy was again used to 
discovered altered trafficking pathways in a disease model (Goldstein and Brown, 1973; 
Brown and Goldstein, 1974; Goldstein et al.,1979). In this work, Michael Brown and 
Joseph Goldstein set out to characterize the cellular phenotypes of the Familial 
Hypercholesterolemia (FH) disorder. They discovered that Low Density Lipoprotein 
(LDL) binds to a specific cell surface receptor for its uptake and it is this receptor that is 
mutated in FH. These findings not only led to therapeutics for FH, but it was the first 
description of receptor-mediated endocytosis; Goldstein and Brown were awarded the 
Nobel Prize in 1985 for their discoveries.  
 Between the 1980s and 1990s, much was learned about the components of the 
endocytic vesicles, but the next wave of discoveries came with the development of GFP-
labeling and live-cell imaging. In 1999, clathrin-mediated endocytosis (CME) was 
visualized for the first time in real-time by tagging clathrin with GFP (Gaidarov et al., 
1999). Live-cell imaging revolutionized the endocytic field and much has been learned 
since about the highly regulated order of events that are critical for proper internalization 
by the plasma membrane.  
 
Endocytosis and Human Disease 
 Like all necessary basic cellular functions, disruption of endocytosis causes 
disease. Misregulated endocytic trafficking pathways are common phenotypes found in 
various cancers and neurodegenerative disorders (reviewed in Zhang, 2009 and Mosesson 
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et al, 2008). Additionally, some endocytic proteins have been implicated in specific 
diseases, such as Parkinson’s Disease, Huntington’s Disease, Alzheimer’s Disease, and 
Downs Syndrome. Thus, it is imperative to understand the complexities of CME in order 
to find suitable therapeutic targets.   
 The main characteristic of cancer cells is their ability to evade death and 
proliferate freely. These actions require that cells alter the regulation of signaling 
pathways important for growth, death, migration, and adhesion. One method some 
cancers use to regulate these pathways is via altering the trafficking of proteins involved 
(Mosesson et al, 2008). Defective endocytic trafficking is a newly characterized hallmark 
of malignant cancer cells. Many cancers have been found to have aberrantly expressed 
endocytic proteins, including clathrin heavy chain, cortactin, Eps15, ITSN1, and 
HIP1/HIP1/R among many others (Ross et al., 1998; Bridge et al., 2001; Argani et al., 
2003; Rao et al., 2003; So et al., 2003; Buday et al., 2007; Gu et al., 2015). By 
controlling endocytosis, cancer cells can reduce down regulation of growth signaling by 
delaying the internalization of the cell surface receptors. Additionally, cancer cells can 
upregulate migration and control adhesion via endocytosis. Further characterization of 
how cancer controls and regulates endocytosis to promote its metastasis is essential for 
finding therapeutic targets.  
 Neurons depend on proper synaptic vesicle (SV) trafficking in order to relay 
signals; a key hallmark of neurodegenerative diseases is dysfunction of SV trafficking 
due to misregulation of exo- and endocytosis. Three neurodegenerative disorders: 
Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and Huntington’s Disease (HD) 
are characterized by accumulation and aggregation of misfolded protein fragments; the 
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cleavage and processing of these fragments depends on the endocytic trafficking. 
Although the exact mechanism of pathogenesis is still murky, it is thought that the 
protein aggregates alter endocytic dynamics leading to alterations of SV recycling and, 
eventually, neurodegeneration.  
 In PD, the accumulation of α-synuclein (α-syn) in dopaminergic neurons leads to 
neurodegeneration; as a result, PD patients experience resting tremors, hypokinesia, 
rigidity, and postural instability. The α-syn aggregates in intracellular inclusions called 
Lewy Bodies. One common mutation found in PD patients is in the LRRK2 gene, a 
protein that has been implicated in the regulation of SV cycle and can interact with some 
endocytic proteins (reviewed in Esposito et al., 2011). It is thought that these LRRK2 
mutant proteins may contribute to the altered SV dynamics found in PD neurons.  
 HD is an autosomal dominant neurological disease, which manifests as 
involuntary movement, cognitive impairment, and emotional disturbance. The disease is 
caused by mutation of the Huntingtin (Htt) protein that expands an N-terminal 
polyglutamine stretch leading to altered biochemical and biophysical properties 
(reviewed in Qin and Gu, 2004). The N-terminus of mutated Htt is cleaved and processed 
though the endosomal-lysosomal system and these fragments localize to intracellular 
inclusions and aggregates (Kegel et al., 2000). These inclusions and aggregates are 
thought to contribute to misregulation of endocytosis and neurodegeneration. 
Additionally, HIP1, Huntingtin Interacting Partner 1, is directly involved in CME as a 
coat/adaptor protein and binds to wild-type, but not mutated, Htt (Kalchman et al., 1997; 
Wanker et al., 1997; Engqvist-Goldstein et al., 1999; Metzler et al., 2001; Waelter et al., 
2001).  
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 AD is a progressive neurodegenerative disease that is the leading cause of 
dementia.  Two hallmarks of AD are the accumulation of extracellular amyloid-β (Aβ) 
plaques composed of a fragment of the amyloid-precursor protein (APP) and intracellular 
neurofibrillary tangles of the tau protein. However, increasing evidence supports that 
prior to the formation of tangles, extracellular and intracellular soluble amyloid-β 
oligomers (oAβ) are the toxic species of Aβ which are responsible for synaptic 
dysfunction and neuronal death in AD, although the initial mechanisms leading to 
dysfunction are unclear (Minano-Molina et al., 2011; Benilova et al., 2012). 
Misregulation of endocytosis is a common phenotype seen in the brains of AD patients 
and mouse models of AD. Further, several endocytic proteins, including PICALM 
(Yap1802), Intersectin, Sla1, and Inp52 have been implicated in AD (Cataldo et al., 
2000; Dunckley et al., 2006; Wilmot et al., 2008; Harold et al., 2009; Thomas et al., 
2011; Treusch et al., 2011). Recent work has shown a role for CME in Aβ-induced 
growth cone collapse, which leads to neurodegeneration and memory impairment; 
inhibition of CME can reverse these effects in vivo (Kuboyama et al., 2015).   
 Endocytosis and trafficking of misfolded proteins seem intimately linked in these 
disorders, but the exact mechanism leading to disease and neuronal dysfunction is 
unknown. Further research of this endocytic misregulation is crucial for understanding 
the pathogenesis of these disorders. 
 
Clathrin-mediated endocytosis 
 Although cells have evolved several mechanisms for endocytosis, the most well 
conserved and well studied is Clathrin-Mediated Endocytosis (CME). As the name 
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implies, CME is differentiated from other modes of endocytosis by the presence of 
clathrin—a protein that forms a cage-like structure around the nascent vesicle. CME 
requires the coordination of over 60 proteins that arrive to plasma membrane at the 
endocytic site or “patch” in a specific order to recognize the cargo that is to be 
internalized, induce membrane curvature to form the vesicle, and bind together to form a 
coat around the nascent vesicle. The process begins with clathrin, adaptor proteins, and 
cargo converging at the site; adaptor proteins are so called because they link the clathrin 
coat to the cargo and the membrane. Next, several other coat proteins are recruited, many 
of which bind and/or regulate actin polymerization. Once the coat and cargo are stable, 
actin, which binds the coat proteins, is polymerized and the force created is used to pull 
the membrane into the cell. Scission factors pinch off the vesicle at the neck near the 
plasma membrane and the now completed vesicle is propelled into the cytosol. Various 
events mediate the un-coating of the vesicle. Finally, the vesicle delivers its cargo within 
the cell and the endocytic proteins are recycled back to the membrane for another round 
of endocytosis.   
 
Conservation of CME from yeast to humans 
  All eukaryotic cells use CME as one of many methods for internalization of the 
plasma membrane and cargo. Saccharomyces cerevisiae is an ideal model system for 
genetic and molecular studies of CME as both the order of events, as well as the proteins 
involved, are well conserved from yeast to humans. Only three main differences have 
been found between the yeast and mammalian CME: the adaptor proteins, necessity of 
actin polymerization, and scission mechanisms.  
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 CME starts with the recruitment of clathrin, cargo, early-arriving proteins 
(Eps15/Ede1), and adaptors to the site of endocytosis on the plasma membrane. In 
mammals, the heterotrimeric adaptor complex AP-2 is the “core” adaptor protein and is 
crucial for most CME events as it binds numerous cargo proteins (reviewed in Sorkin, 
2004). However, AP-2, while present in yeast, is not essential for CME, does not bind 
clathrin, and only has one known cargo: K28 killer toxin (Huang et al., 1999; Yeung et 
al., 1999; Carroll et al., 2009). Instead, yeast use four adaptor proteins that are partially 
redundant: Yap1801/2 (CALM/AP180s) and Ent1/2 (Epsins) (Maldondo-Baez et al., 
2008; Burston et al., 2009). As there are hundreds of various cargos that need to be 
internalized either specifically or in bulk, it is necessary for cells to have both specific 
and non-specific adaptor proteins. Both yeast and mammals have accessory adaptor 
proteins, including FCHO1/2/Syp1, HIP1R/Sla2, and Sla1/Cin85 (Wesp et al., 1997; 
Yang et al., 1999; Henry et al., 2002; Howard et al., 2002, Piao et al., 2007, Reider et al., 
2009).  
 The Arp2/3 complex is at the center of actin polymerization in both yeast and 
mammalian CME. The proteins that activate the Arp2/3 complex are conserved: N-
WASP/Las17, Syndapin/Bzz1, Intersectin/Pan1, and the Type 1 Myosins/Myo3/5. While 
the actin polymerization process is very similar in yeast and mammals, it is the necessity 
of this step that differs: it is essential for all CME events in yeast, but not in mammals. If 
actin polymerization is disrupted in yeast cells either by mutating actin regulatory 
proteins or the addition of the actin depolymerizing drug Latrunculin A, then CME is 
either greatly reduced or arrested (Kaksonen et al 2003, 2005; Newpher and Lemmon, 
2006). It is thought that the inward force of actin polymerization is necessary for the 
8
membrane to overcome the outward force of turgor pressure created by the cell wall; 
removal of the cell wall to relieve this pressure results in an increase in CME 
(Aghamohammadzadeh and Ayscough, 2009; Basu et al., 2014). In mammalian cells, 
actin polymerization is only necessary when internalizing a large cargo or in regions of 
increased pressure, such as between tight contacts of cells (Saffarian et al., 2009; Collins 
et al., 2011). Thus, while the mechanisms of the actin polymerization step are very well 
conserved, the necessity varies depending on species and circumstances.  
 The final difference between yeast and mammals is in the mechanism of fusion of 
the opposing membranes to close the vesicle and pinch it off from the plasma membrane. 
Both yeast and mammals use amphiphysins (yeast: Rvs161/167) that contain BAR 
domains to bring the opposing membranes together (Wigge et al., 1997; Lombardi and 
Riezman, 2001). In mammals, dynamin uses GTP hydrolysis to pinch off the membrane 
(Sever et al., 2000). However, the contribution of the yeast dynamin homologue, Vps1, to 
CME is not certain. It is thought that amphiphysins and the force of actin polymerization 
may be enough to pinch off the vesicle, but growing evidence hints that Vps1 may 
coordinate with Rvs167 in this step (Nothwehr et al., 1995; Yu and Cai, 2004; 
Nannapaneni et al., 2010; Smaczynska-de Rooij et al., 2010).  
 Although there are some differences between yeast and mammalian CME events, 
they are similar enough that much can be learned from doing experiments in yeast and 





Regulation of Endocytosis—Remaining Questions  
 Although much has been learned in the past six decades about the components 
and order of events of CME, there are still several remaining questions regarding the 
exact mechanisms of regulation at each step of endocytosis. CME can be broken down 
into four stages based on the arrival of certain protein modules: early coat, late coat, actin 
polymerization, and scission/uncoating. We know many of the proteins that arrive during 
each stage and how they bind each other, but why do they arrive at that time? The first 
stage, the early coat, has a highly variable lifetime at the endocytic patch, but the other 
three stages have a more predictable lifetime. It is hypothesized that there is some 
checkpoint that occurs before the wave of recruitment of the final three coats--what 
protein interactions are important for the sequential recruitment? What protein(s) signal 
that the patch is ready to mature? Does the amount or identity of the cargo play a role in 
the transition? N-WASP/Las17, the strongest actin nucleator in CME, is recruited with 
the late coat yet remains inhibited until some unknown signal indicates that the 
membrane is ready to be invaginated. During this invagination, why do some proteins 
remain at the plasma membrane, while others internalize at the tip of the expanding 
vesicle? What interactions are important for maintaining the coat structure during the 
actin polymerization?  
 We hypothesize that there are one or more key coordinators that act as scaffolds 
throughout CME to help transition between stages. These scaffold proteins would need to 
have several binding regions for many protein interactions. Flexibility would also be 
necessary in order to properly transition and change interactions during each stage. Two 
proteins stand out as possible candidates for these coordinator roles: Eps15/Ede1 and 
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Intersectin/Pan1. Recently, Ede1 was proven to be critical for the initiation of CME and 
formation of the early coat (Boeke et al., 2014). And while its presence is important for 
the late coat, it is unable to properly regulate all of those interactions. This dissertation 
provides evidence that Pan1 is the key coordinator for the late coat. Thus, Eps15/Ede1 
and Intersectin/Pan1 may function together to initiate and form the early coat, recruit the 
late coat, and provide overall structural organization to the entire CME clathrin coat.  
 
Intersectin 
 The mammalian protein Intersectin (ITSN) is so named because it has roles in 
both endocytosis and cellular signaling and thus is thought to act at the intersection 
between these pathways. ITSN was first discovered in a screen for Src homology 3 (SH3) 
containing proteins in Xenopus laevis oocytes; upon further characterization it was found 
to contain 5 SH3 domains and 2 Eps15-homology (EH) domains, both of which are 
commonly found in endocytic machinery (Yamabhai et al., 1998). Based on this analysis, 
ITSN was proposed to be a CME component. Later work found that ITSN is involved in 
several cellular signal transduction pathways independent of its endocytic scaffolding 
function (reviewed in Tysba et al., 2011). In addition, ITSN has been implicated in 
cancer and several neurological diseases, including Alzheimer’s Disease, Downs 
Syndrome, and Huntington’s Disease (Scappini et al., 2007; Hunter et al., 2011).  
 ITSN is a multi-domain scaffold protein that contains two N-terminal EH 
domains, a central coiled-coil region, five SH3 domains, and a variably expressed actin-
regulatory region (Figure 1.1) (Guipponi et al., 1998; Yamabhai et al., 1998). These 

















































































































































































































































other endocytic proteins (Adams et al., 2000). Through its EH domains, ITSN binds Asn-
Pro-Phe (NPF) tripeptide motif containing proteins, such as the adaptor proteins 
Epsin1/2; the coiled-coil region binds another coat protein Eps15 (Yamabhai et al., 1998; 
Sengar et al., 1999). The five SH3 domains in ITSN, which bind proline-rich sequences, 
provide the most broad functional binding regions as they interact with proteins involved 
in signaling, cytoskeletal organization, and membrane trafficking (Li et al., 2005, Tsyba 
et al., 2011). Although there are several putative serine/threonine phosphorylation sites 
throughout ITSN, the function of these sites has yet to be investigated (Ballif et al., 2004; 
Tweedie-Cullen et al., 2009). Finally, ITSN has three C-terminal regions that are present 
in the long isoforms: Dbl homology domain (DH), Pleckstrin homology domain (PH), 
and C2 domain (Guipponi et al., 1998; Sengar et al., 1999). ITSN activates Cdc42 
through coordination of the DH and PH domains and Cdc42 then stimulates WASp to 
promote the activation of Arp2/3 (Hussain et al., 2001). Both the PH and the C2 domain 
can bind ITSN to lipid membranes (Rizo and Sudhof, 1998).   
 ITSN homologues are found in several eukaryotic organisms, including 
Drosophila melanogaster (Dap-160), Xenopus laevis (X-ITSN), Caenorhabditis elegans 
(ITSN-1), Cryptococcus neoformans (Cin1), and Saccharomyces cerevisiae (Pan1) (Roos 
and Kelly, 1998; Yamabhai et al., 1998; Okamoto et al., 1999; Sengar et al., 1999; Rose 
et al., 2007). ITSN is only essential in some cell types and organisms due to its 
redundancy with other ITSN genes; mammals have two ITSN genes: ITSN1 and ITSN2, 
both of which have a long and a short isoform. While ITSN2 is ubiquitously expressed in 
all tissues, ITSN1-long is primarily found in neurons (Guipponi et al., 1998; Pucharcos et 
al., 1999, 2000, 2001). A double knockout of ITSN1/2 is lethal and 1 out of every 8 
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ITSN1 knockouts dies shortly after birth. Interestingly, the viable pups have no gross 
phenotypic differences besides a reduced rate of synaptic vesicle endocytosis (Yu et al., 
2008). ITSN is a scaffolding protein that can form oligomers and is therefore sensitive to 
changes in concentration; thus both overexpression and reducing ITSN levels beyond the 
optimal concentration can cause similar effects. Overexpression and silencing of ITSN in 
cells leads to a disruption of endocytosis and silencing ITSN leads to an increase in early 
endosome size (Sengar et al., 1999; Pucharcos et al., 2000; Martin et al., 2006; Thomas 
et al., 2009).  
 The numerous binding regions of ITSN allow it to serve as a scaffolding protein 
not only in endocytosis, but also in several signaling pathways (reviewed in Tysba et al., 
2011). In its endocytic role, ITSN is critical for receptor tyrosine kinase (RTK) signaling 
because CME is important for down regulation of activated RTKs by removal of the 
receptor from the cell surface. However, ITSN can also act independently of endocytosis 
in stimulation of the Elk-1 transcription factor (Mohney et al., 2003; Patel et al., 2013). 
Through a yet uncharacterized pathway, ITSN’s EH domains can activate JNK-
dependent signaling cascades (Adams et al., 2000; Mohney et al., 2003). Finally, in D. 
melanogaster, ITSN has been shown to directly interact with and activate aPKC and 
PAR6, which are part of a cell polarity complex important for asymmetric cell divisions 
(Nishimura et al., 2007; Chabu et al., 2008; Gonczy, 2008). Although this function hasn’t 
been found in mammalian cells yet, ITSN can interact with Numb, which is a PAR 
complex activator (Nishimura et al., 2006). 
 ITSN is a large, complex protein, yet the acute details of all of its functions are 
difficult to study due to redundancies and its essential nature. Pan1 shares many of the 
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same binding regions, interacting partners, and functions, and is therefore an ideal model 
system for a more careful study of this family of scaffolding proteins.  
 
Implications of Intersectin in Human Disease 
ITSN1 is a key component of endocytosis in neurons, thus any mutations in ITSN 
could lead to misregulation of SV recycling, a common phenotype of neurological 
disorders. Two hallmarks of AD, endocytic misregulation and an increase in early 
endosome size, resemble phenotypes seen in overexpression and silencing of ITSN. 
(Cataldo et al, 1997, 2000; Pucharcos et al., 1999; Predescu et al., 2003; Koh et al., 2004; 
Marie et al., 2004; Yu et al., 2008; Treusch et al., 2011). Although there is currently no 
direct link between ITSN1 and AD, ITSN1 transcript and protein levels are altered in AD 
patients (Dunckley et al., 2006; Wilmot et al., 2008). In humans, the ITSN1 gene is on 
chromosome 21 and is trisomied in Downs Syndrome patients, leading to increased 
protein expression (Pucharcos et al., 1999). All DS patients develop early-onset AD-like 
neuropathology; therefore, proteins expressed from genes located on the triplicated 
region of chromosome 21, such as ITSN, may be causal to AD and DS. Neurons in DS 
patients, like AD, have large early endosomal compartments, which is characteristic of 
ITSN1 overexpression (Pucharcos et al., 1999; Cataldo et al., 2000, 2004; Predescu et al., 
2003; Yu et al., 2008).  
Independent of its role in endocytosis, ITSN1 is involved in several signaling 
pathways. Through activation of the JNK-MAPK pathway, ITSN1-S has been implicated 
in increasing the aggregation of mutant Htt protein in HD (Mohney et al., 2003; Scappini 
et al., 2007). Thus, ITSN could be a potential therapeutic target for HD, AD, and DS.  
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The short isoform of ITSN1 is overexpressed in glioblastoma cells and there is evidence 
that ITSN1-S is essential for glioblastoma cell proliferation through its role it the 
RAF/MEK/ERK signaling cascade (Gu et al., 2015).  The precise roles of ITSN are 
difficult to study because there are two ITSN genes in mammals that both express 
numerous isoforms. The double knockout of ITSN1/2 is lethal, and the redundancy of the 
proteins makes experiments with single knockouts difficult to interpret. Research on 
more simple organisms, such as yeast, can be done to characterize the role of the ITSN 
family proteins.  
 
Pan1  
 In 1992, Pan1 was erroneously identified as a poly(A) ribonuclease binding 
protein; this was corrected in 1996, the same year that Pan1 was found in two separate 
genetic screens to be important for actin cytoskeletal organization and endocytosis (Sachs 
and Deardorff, 1992; Boeck et al., 1996; Tang and Cai, 1996, Wendland et al., 1996). 
Over the last two decades, Pan1’s role in CME has been defined by its abundant binding 
interactions to other endocytic proteins and its localization dynamics at the endocytic 
patch. The precise details of Pan1’s mechanistic functions have yet to be described due to 
the fact that Pan1 is essential, making deletion experiments impossible.  
 The two genetic screens that identified Pan1 used temperature sensitivity (ts) to 
find candidate protein alleles. The Cai lab screened for mutants that were synthetically 
lethal with a CDC28 mutation (Tang and Cai, 1996). The pan1-4 allele was found and 
described to be required for normal actin cytoskeletal organization; this disorganization 
let to abnormal bud growth and defective cytokinesis. The Emr lab screen found mutants 
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that had inefficient uptake of the lipophilic dye, FM4-64 (Wendland et al., 1996). This 
screen found the pan1-20 allele, which in addition to its endocytic defects also displayed 
abnormal actin phenotypes, including loss of polarity of cortical actin patches and thicker 
actin bundles.  
 Pan1 binds several other proteins in the early, late, and actin polymerization 
stages of CME. At its N-terminus, Pan1 has two EH domains that are 72% similar, but 
only the second can bind to the adaptor proteins Ent1/2 and Yap1801/2 via their NPF 
motifs (Salcini et al., 1997; Paoluzi et al., 1998; Wendland and Emr, 1998; Wendland et 
al., 1999; Maldonado-Baez et al., 2008). The C-terminus of Pan1 has been implicated in 
binding to the early arriving protein, Ede1 via its coiled-coil region (S. Barker and B. 
Wendland, unpublished observations). Through a yet unspecified domain in the first of 
Pan1’s N-terminal long repeat (LR) regions, Pan1 interacts with Sla2 (Toshima et al., 
2005; 2007). Pan1 has the strongest interactions with proteins in the late coat. Pan1 forms 
a complex with Sla1 and End3, which bind its N-terminus and central region, 
respectively (Tang et al., 1997; 2000; Whitworth et al., 2014). While the Pan1-End3 
interaction is stable at the patch and in the cytosol, Ark1/Prk1 phosphorylation of both 
Sla1 and Pan1 leads to their dissociation at the uncoating step of CME (Tang et al., 2000; 
Zeng et al., 2001; Toshima et al., 2005; 2007, Boeke et al., 2014). Both proteins are 
dephosphorylated by Glc7 to allow their participation in the next round of CME (Zeng et 
al., 2007). Pan1 can also bind itself and form homo-dimers and homo-oligomers via its 
central region (Miliaras and Wendland, 2004; Pierce et al., 2013). Finally, Pan1 can both 
bind F-actin via a WH2-like motif, activate Arp2/3 through its acidic domain, and bind 
Myo3/5 in the proline-rich domain (PRD) (Duncan et al., 2001; Barker et al., 2007, 
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Toshima et al., 2005). There are two putative regions of Pan1 that may be involved in an 
undiscovered Pan1 function: nuclear localization signals (NLS) and a Hog1-dependent 
stress-induced phosphorylation site (Kaminska et al., 2005, Reiter et al., 2012). Further 
research is required in order to confirm their validity and discover if/how these domains 
function in endocytosis or Pan1’s essential role.    
 Like ITSN, Pan1 is a large protein with several diverse binding regions and 
domains; it contains two N-terminal EH domains, a central coiled-coil region, and a C-
terminal actin regulatory region (Figure 1.1). Although Pan1 does not contain the five C-
terminal SRC homology-3 (SH3) domains like ITSN, it does form a complex with Sla1, 
which contains three SH3 domains (Tang et al, 2000). Both Pan1 and ITSN interact with 
early arriving proteins, including adaptors and Eps15/Ede1 through conserved regions 
(Salcini et al., 1997; Paoluzi et al., 1998; Wendland and Emr, 1998; Yamabhai et al., 
1998; Sengar et al., 1999; Wendland et al., 1999; Koh et al., 2007; Maldonado-Baez et 
al., 2008; Pechstein et al., 2010; S. Barker and B. Wendland, unpublished observations). 
They both interact with various CME coat proteins and can promote actin polymerization 
either directly or indirectly. ITSN has important signaling functions in mammalian cells, 
which leads us to believe that Pan1 may also be playing other, perhaps similar, signaling 
roles in S. cerevisiae. Much is still unknown about the mechanistic roles of ITSN in 
CME; the ease and genetic tractability of using yeast to study Pan1’s essential roles may 





Methods for studying essential proteins 
 While yeast is a fantastic model system for uncovering specific details regarding 
the function of a majority of proteins, it does have limitations. The majority of yeast 
proteins are not critical for viability, allowing for simple gene deletion experiments for 
observation of the resulting phenotypes. However, this method does not work for the over 
1000 essential yeast genes, which represent 18% of all open reading frames in S. 
cerevisiae (Nash et al., 2007). There are numerous methods for mutating genes or 
conditionally inactivating essential proteins, each of which have advantages and caveats. 
Thus, it is important to use a combination of these methods to get a more complete 
picture of a protein’s cellular function.   
 One of the most-widely used methods to study a protein is to generate 
temperature sensitive (ts) mutant alleles in which all or some of the functions of a protein 
are lost upon the switch to a higher or lower temperature. These mutations typically 
disrupt the folding of the protein leading to altered binding dynamics, localization, 
activity, or it targets the protein for degradation. These alleles can help clarify some of 
the protein’s role, but often the mutation does not disrupt all of the protein’s functions. 
Additionally, the insult of the temperature shift activates cellular stress pathways, which 
can complicate observations.  
 Another popular method is to alter the transcription levels of a gene using 
promoters that respond to changes in the levels of galactose (GAL1), methionine 
(MET25), or tetracycline (TetON/OFF) in the media (Johnston and Davis, 1984; 
Mountain et al., 1991; Belli et al., 1998). While the GAL1 and MET25 promoters have 
the advantage of being natural yeast promoters, their activation requires a change in 
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cellular metabolism and their regulation is often not perfect. Tetracycline promoters 
avoid this metabolism switch, but do not avoid the biggest disadvantage of conditional 
promoters—long half-lives of proteins. Even if a gene is not being actively transcribed 
and translated, there is still previously made protein in the cell, which may take hours or 
days to degrade. This remaining protein causes a phenotypic lag, which makes acute 
observations due to the absence of a protein impossible.  
 Another way to study a protein is to alter the protein’s translation levels via the 
DAmP method: Decreased Abundance by mRNA Perturbation (Schuldiner et al., 2005). 
Hypomorphic alleles are generated by insertion of an antibiotic resistance cassette into 
the 3’ untranslated region (UTR) of the target gene, thus destabilizing the corresponding 
transcript leading to a decrease in mRNA and protein levels. This method allows a 
protein to remain functional, but the decreased levels will alter the efficiency of the 
pathways in which it is involved, giving insight into the protein’s role. Obviously, the 
main caveat of this method is that the some of the protein is still expressed and 
functional.  
 The final methods used to discover a protein’s function focus on conditional 
expression of the target protein, instead of altering its encoding gene. If a protein is 
known to function in a particular location, a tag can be added to the protein that will, 
under the nonpermissive conditions, relocalize and “anchor” the protein to another 
location; for example, a nuclear protein can be anchored to the cytoplasm (Chen et al., 
1995; Belshaw et al., 1996; Haruki et al., 2008). This method uses the natural 
dimerization of mTOR proteins that occurs in the presence of rapamycin. Rapamycin is 
toxic to yeast and thus yeast cells must be made rapamycin-resistant in order for these 
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“anchor away” experiments to be successful. However, the addition of rapamycin can 
have off-target effects on the cells that can confuscate results.  
 Lastly, the cells’ endogenous ubiquitin-mediated degradation system can be used 
to conditionally degrade the target protein. In these degron alleles, a degron tag is added 
to the target protein and a corresponding E3 ligase is expressed in the cells. Upon the 
switch to nonpermissive conditions, the degron tag is recognized by the E3 ligase, 
leading to polyubiquitination and subsequent proteasome proteolysis of the target protein. 
Two of these degron tags, the DHFR and TIPI tags, depend on the N-end rule, which 
states that the in vivo half-life of a protein depends on the identity of the N-terminal 
amino acid (Bachmair et al., 1986; Varshavsky, 1996; Sanchez-Diaz et al., 2004; Taxis et 
al., 2009). In both of these degron tags, the N-terminal amino acid is unstable in the 
nonpermissive conditions and is recognized by the E3 ubiquitin ligase Ubr1. While both 
of these methods are successful in recognition and degradation of their target proteins, the 
nonpermissive conditions are not ideal—often a carbon source or temperature shift is 
required for expression of Ubr1 and exposure of the unstable N-terminal degron residue. 
Additionally, Ubr1 is endogenous to the cells and its overexpression can lead to the 
degradation of non-target proteins. To avoid these caveats, the Auxin Inducible Degron 
(AID) method was developed using a plant based degradation system to avoid 
endogenous targets (Nishimura et al., 2009). In the AID method, the target protein is 
tagged with a small plant protein, the “AID” tag and the plant E3 ligase TIR1 is 
constitutively expressed in the cells. TIR1 only recognizes the AID tag upon the addition 
of the plant hormone auxin to the media. Because TIR1, AID, and auxin are all plant 
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specific they should not have any endogenous targets in yeast and should not cause 
additional stress on the cells.  
 Pan1 is an essential protein and much has been learned about its functions through 
the use of ts mutant alleles. Attempts have been made to conditionally control PAN1, 
however, PAN1 contains many methionines and internal start sites that allow truncated 
versions of Pan1 lacking any 5’ UTR sequences to be expressed constitutively (Tang and 
Cai, 1996; K. Whitworth and B. Wendland, unpublished observations). Temperature and 
metabolism shifts are not ideal for experiments on endocytosis as these conditions perturb 
endocytic dynamics. This dissertation describes the development of the Pan1-AID degron 
allele and its use to elucidate the mechanisms of Pan1’s role in endocytosis. The Pan1-
AID allele is also used to carefully annotate which regions and domains of Pan1 are 
critical for each of its known functions.  
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 Much of the previous work on Pan1 used conditional mutants found through 
genetic screens (temperature sensitive (ts) alleles) or with engineered point mutations or 
truncations. However, findings from using the ts alleles are confounded by the effects of 
the nonpermissive conditions, which can also adversely affect endocytosis and all of 
these allele experiments are chronic and could be subject to compensatory changes. 
Additionally, it is not known if these alleles completely remove all Pan1 functions or just 
some of them. Attempts to make a conditionally expressed Pan1 allele were unsuccessful 
to due putative alternative translational start sites within Pan1 that made these alleles 
“leaky” by expressing truncated protein even in the nonpermissive conditions (Tang and 
Cai, 1996; K. Whitworth and B. Wendland, unpublished observations). For these reasons, 
it was necessary to create a degron allele of Pan1 that acutely and specifically degrades 
Pan1 protein in vivo. We used an Auxin-Inducible Degron (AID) to deplete cells of Pan1 
protein in vivo (Nishimura et al., 2009). Upon addition of auxin to the Pan1-AID cells, 
Pan1 is quickly degraded, endocytosis is arrested after one hour, and the cells start to die 
after 4-5 hours. These early time-points were used to assess the acute phenotypes of Pan1 









 Work with pan1 mutant alleles suggests roles for Pan1 in endocytosis, actin 
cytoskeletal organization, polarized cell growth, and mitochondrial protein sorting 
(Zoladek et al., 1995; Tang and Cai, 1996; Wendland et al., 1996; Bidlingmaier et al., 
2001; Kamińska et al., 2005). However, its precise mechanistic role(s) in these pathways 
is unknown, nor is it known which of these, if any, corresponds to Pan1’s essential 
function(s). Although Pan1 has been characterized as a clathrin-mediated endocytic 
(CME) protein, CME is not an essential process, thus begging the question of what is 
Pan1’s essential function if not in CME? Pan1 binds early and late endocytic factors, thus 
we hypothesized that its deletion would cause misregulation of recruitment of endocytic 
proteins to and lifetimes at the patch. In addition, although Pan1 is itself not a strong 
regulator of actin polymerization, it does bind several proteins involved in actin 
polymerization (both promotion and inhibition); therefore, it is predicted that Pan1 
deletion could cause aberrant actin structure formation (Duncan et al., 2001; Toshima et 
al., 2005; Barker et al., 2007). The exact mechanisms of Pan1’s function was difficult to 
discern due to its essential nature. 
 Much of the previous work on Pan1 has been done using temperature sensitive 
(ts) conditional mutants; however, findings using ts alleles are confounded by the effects 
of the nonpermissive conditions, which can adversely affect endocytosis and elicit a 
stress response. Further, these allele experiments are chronic and could be subject to 
compensatory changes. Finally, it is not known if these alleles remove some or all Pan1 
functions. Conditional expression of Pan1 has been unsuccessful due to putative 
alternative translational start sites and “leaky” expression of truncated protein even in the 
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nonpermissive conditions (Tang and Cai, 1996). Thus it was necessary to create a degron 
allele of Pan1 that acutely and specifically degrades Pan1 protein in vivo. An initial Pan1-
degron, pan1-td, relied on both an increase in temperature and a change in carbon source 
to initiate degradation of Pan1 (K. Whitworth and B. Wendland, unpublished 
observations). This degron allele was not ideal due to the non-permissive conditions 
having off target effects on the phenotypes observed (discussed in Appendix I). Thus, a 
different degron tag that eliminated these stress-inducing conditions was required for 
studying Pan1. 
We have used the methods of Nishimura et al. (2009) to produce a degron-fusion 
allele of PAN1 (Pan1-AID) in order to efficiently and specifically degrade Pan1 upon 
addition of the plant hormone auxin. The AID method uses the plant specific auxin-
inducible degron system in which certain proteins are recognized for degradation in the 
presence of auxin. In plants, the highly conserved E3 ligase SCF complex binds to 
various F-box proteins, which interact with specific substrates only in the presence of 
auxin to promote the substrate’s degradation.  In the Pan1-AID strain, the plant F-box 
protein TIR1 is constitutively expressed with the ADH1 promoter and PAN1 is C-
terminally fused with the Arabidopsis thaliana TIR1 target protein IAA17 (AID tag). In 
the absence of auxin, TIR1 binds the SCF complex, but does not interact with the AID 
tag. Upon addition of auxin, TIR1 binds auxin, which promotes the interaction between 
TIR1 and the AID-tag. This interaction recruits an E2 ubiquitin conjugating enzyme, 
which promotes the ubiquitination and subsequent degradation of Pan1-AID (Figure 
2.1A).  Expression of TIR1 does not alter growth of yeast; furthermore, TIR1 does not 
have any endogenous yeast targets because it is a plant protein. Thus, this system allows 
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for specific of degradation of only proteins with an AID tag. Pan1-AID is viable in the 
absence of auxin, allowing for propagation of the strain. Under the nonpermissive 
conditions, the cells are inviable and endocytosis is arrested. The Pan1-AID allele thus 
provides a novel, effective way to study the functions of Pan1 using acute perturbations 




















MATERIALS AND METHODS 
Media and Growth Conditions 
Yeast cells were grown in rich (yeast extract-peptone) or synthetic (yeast nitrogenous 
base with amino acids selection of plasmid maintenance) medium with 2% dextrose. For 
experiments using auxin in liquid cultures, 3-Indoleacetic acid (Sigma I2886) was added 
to synthetic media to a final concentration of 500µm. For experiments using auxin on 
solid media, 1-Naphthaleneacetic acid (Sigma N0640) was added to synthetic media to a 
final concentration of 1mM. For cell-death and growth experiments, sorbitol was added at 
a final concentration of 1M, rapamycin was added at a final concentration of 0.2µg/ml 
and cycloheximide at a final concentration of 0.1µM.  
 
Strains and Plasmids 
The yeast strains and plasmids used in this study are listed in Tables 2.1 and 2.2, 
respectively. Strains were constructed using PCR-based genomic integration as described 
previously (Longtine et al., 1998; Goldstein and McCusker, 1999; Nishimura et al., 
2009). DNA manipulations for plasmid construction were preformed using standard 
techniques, employing either T4 DNA polymerase-mediated ligations in Escherichia coli 
or homologous recombination with overlapping DNA fragments followed by plasmid 
rescue in S. cerevisiae. All restrictions enzymes were purchased from New England 








TABLE 2.1 Yeast strains used in this chapter 
Strain Genotype Source 
W303 










MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 
can1-100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 
HisΔ::URA This Study 
BWY5394 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ADH1-OsTIR1-9myc::URA3 ade2::ADE2 
HisΔ::URA Pan1-AID::G418 This Study 
BWY6051 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Mup1-pHl::HPH This Study 
BWY6052 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 
HisΔ::URA  Ade8Δ::LEU Mup1-pHl::HPH This Study 
BWY6053 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 
HisΔ::URA Pan1-AID::G418 Ade8Δ::LEUMup1-
pHl::HPH This Study 
 
TABLE 2.2 Plasmids used in this chapter 
Plasmid Details Description Source 
pRS414 CEN, TRP1  Empty Vector (EV) 
Laboratory 
plasmid 
pBW626 pRS414::PAN1 (CEN, TRP1) pPan1.414 




TCA Precipitation:  
Mid to late-log phase cells -/+ Auxin at indicated time points were harvested and 
resuspended in 1ml of 10% trichloroacetic acid (TCA) with 1mM 4-(2-
aminoethyl)benzenesulfonyl fluoride (AEBSF, a protease inhibitor), incubated on ice for 
20 min, and precipitates were centrifuged at 14,000 rpm for 10 min at 4°C. Precipitates 
were washed twice with cold acetone, resuspended by sonication, and air-dried. Protein 
samples were processed for SDS-PAGE separation by adding 2x protein sample buffer 
with 1mM AEBSF and solubilized by bead disruption.  
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SDS-PAGE and Immunoblotting: 
Proteins were separated on polyacrylamide mini gels (7.5%) at 27mA in SDS running 
buffer (3mM SDS, 25mM Tris base, 192mm glycine) and then transferred onto 
nitrocellulose membranes at 80V for 90 min in cold transfer buffer (20% methanol, 
0.0375% SDS, 48mM Tris base, 30mM glycine). The membranes were blocked in 5% 
milk in TBST (10mM Tris, pH 7.5, 0.25M NaCl, 0.025% Tween-20). Blots were 
incubated in the specified primary antibody overnight at the following concentrations: 
Rabbit-anti-Pan1 was a gift from D.G. Drubin and was used at 1:10,000; Rabbit-anti-
Act1 was a gift from D. Pruyne and was used at 1:5,000; Rabbit-anti-End3 was a gift 
from the H. Riesman lab and was used at 1:2,000; and Rabbit-anti-Sla1 was a gift from L. 
Hicke and was used at 1:2,000. The blots were washed 3 times in TBST, incubated with 
secondary antibodies conjugated to HRP (Pierce, Rockford, IL) diluted 1:2,000 in milk 
solution for 45 min. Blots were washed again 3 times in TBST, and then developed with 
chemiluminescent substrate (Solution 1:2.5mM Luminol, 400uM paracoumaric acid, 
100mM Tris-HCl, pH 8.5. Solution 2: 5.4mM H2O2, 100mM Tris-HCl, pH 8.5) for 2 min 
at room temperature. Chemiluminescence images were acquired using a FluorChem M 
FM0455 imager.  
 
Growth Assays 
Serial Dilutions: Log phase cells were diluted to an OD600nm of 0.25, from which four 
1:5 serial dilutions were plated on YNB-tryptophan minus or plus 1mm NAA and grown 
for three days at 30°C.  
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Liquid growth: Log phase cells were diluted to an OD600nm of 0.15 in synthetic media 
minus or plus 500µm IAA in a 24-well clear plate. Absorbance at 600nm was measured 
every 30 m over 16 hours in a plate reader.  
 
Propidium Iodide Staining 
Aliquots of cells from each culture were taken at the indicated times after incubation in 
minus or plus 500µm IAA at 30°C and labeled with 1µg/ml propidium iodide (PI). 5,000 
cells were immediately analyzed on a BD FACS-Calibur (Becton Dickinson & Co., 
Mountain View, CA) flow cytometry system to quantify the population of cells with 
fluorescent propidium iodide staining. For DNA content assays, cells were fixed in 70% 
ethanol overnight and washed in PBS prior to PI staining. Gates were used to count the 
percent of cells with 1N and 2N DNA content.  
 
FM4-64 staining 
FM4-64 images were collected using a Zeiss Axiovert 135TV inverted microscope (Carl 
Zeiss MicroImaging, Inc., Thornwood, NY) with a Sensicam QE CCD camera (Cooke, 
Romulus, MI), Zeiss 100x 1.4 NA Plan-Apochromat objective, motorized filter wheels, 
fluorescein isothiocynate (FITC) and Texas Red filter sets (Semrock, Rochester, NY), 
and Slidebook 5.0 software (Intelligent Imaging Innovations, Denver, CO). Images were 
captured with 500ms exposure, identical binning, intensification and illumination 
intensity. Log phase cells were incubated in YNB-trp media minus or plus 500µM IAA 
for 30 min at 30°C. For FM4-64 labeling, cell aliquots were transferred to an eppendorf 
tube with 10ug/ml FM4-64 (Molecular Probes, Eugene, OR) and incubated for 15 min at 
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30°C. The cells were washed twice with fresh media to remove excess FM4-64, 
resuspended in 100ul fresh media, and then put on ice until visualization at the 




Mup1-pHlourin images were collected using a Zeiss Axiovert 135TV inverted 
microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY) with a Sensicam QE CCD 
camera (Cooke, Romulus, MI), Zeiss 100x 1.4 NA Plan-Apochromat objective, 
motorized filter wheels, fluorescein isothiocynate (FITC) and Texas Red filter sets 
(Semrock, Rochester, NY), and Slidebook 5.0 software (Intelligent Imaging Innovations, 
Denver, CO). Images were captured with 500ms exposure, identical binning, 
intensification and illumination intensity. For quantification of fluorescence intensity, 16-
bit image files were analyzed in Image J v1.41n. Background subtraction was performed 
before measurement of integrated density, and values were corrected for cell size.  
 
To perform kinetic analysis of endocytosis, cells expressing Mup1-pHlourin were grown 
overnight in synthetic YNB media lacking methionine (YNB-met). Cells were then 
diluted to a density of 0.35 OD/ml in YNB-met, and were grown to a density of 0.6 
OD/ml. Cells were then seeded onto concanavalin A-coated 8-well glass-bottomed 
chamber slides (LabTek, Scotts Valley, CA) containing YNB-Met and were allowed to 
settle before imaging. Cells were/were not treated with 500µM IAA for 30 min, then 
methionine was added at a concentration of 20µg/ml and images were captured after 30 
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min or one hr. During image acquisition, cells were maintained at a constant temperature 
of 30°C. Experiments with Pan1 plasmids were performed in YNB-trp-met media.  
 
Electron Microscopy 
Fixation: Log phase cells were incubated in indicated conditions and were fixed 
overnight at 4°C in 10% gluteraldehyde, 0.1 M NaCacod pH 7.4, 5mM CaCl2, 5 mM 
MgCl2, 2.5% sucrose. Samples were washed in subsequent wash steps with: 100mM 
cacodylate, TDES, and then 0.1M phoscitrate/1M sorbitol. To the phoscitrate/sorbitol 
step, B-glucuronidase and 10mg/ml zymolase were added and cells were agitated for one 
hour. Cells were washed with 0.1M cacodylate/5mM CaCl2/1M sorbitol and stored at 
4°C. Cells were emedded in 2% agarose, cut into pieces and fixed in 1% OsO4/1% 
potassium ferrocyanide in 0.1M cacodylate/5mM CaCl2, pH 6.8 at room temperature for 
30 m.  
Osmium-Thiocarbohydrazide-Osmium staining: Blocks were washed in subsequent steps 
with: 1% thiocarbohydrazise, ddH2O, 1% OsO4/1% potassium ferrocynide in cacodylate 
buffer pH 6.8, ddH2O, and then let sit in Kellenberger’s uranyl acetate overnight. Blocks 
were dehydrated through a graded series of ethanol on ice, then transferred to 1:1 
ethanol/propylene oxide, then 100% propylene oxide, then 2:1 propylene oxide/ Epon 
resin overnight. Blocks transferred to beam capsules in fresh Epon resin overnight. 
Samples were sectioned and placed on grids. Electron microscopy imaging was done 





Statistical significance between populations was determined by one-way ANOVA 























Pan1-AID is an efficient tool for depleting Pan1 protein in cells 
 To investigate the function(s) of Pan1, we used the Auxin-Inducible Degron 
(AID) system to acutely deplete cells of Pan1 protein in vivo (Nishimura et al., 2009). 
The Pan1-AID degron cells were created by endogenously C-terminally tagging Pan1 
with the AID sequence and integrating the OsTIR1 gene with the constitutive ADH1 
promoter (Figure 2.1A). OsTIR1 is a plant F-box protein that specifically binds and 
promotes the degradation of the AID tagged target protein only in the presence of auxin. 
For controls, we used a wildtype (WT) strain and a strain containing only OsTIR1 (TIR1) 
with empty vector (EV) plasmids, both of which grew similarly in the absence and 
presence of auxin (Figure 2.1B). In the absence of auxin, Pan1-AID cells grew to WT 
levels and Pan1 protein was stable; upon addition of auxin, growth was arrested and 84% 
of Pan1 protein was degraded within 15 min (Figure 2.1, B-D). Expressing full-length 
Pan1 on a plasmid in Pan1-AID cells restored growth in the presence of auxin (Figure 
2.1, B and C). Depletion of Pan1 was specific and did not affect the stability of its 
binding partners Sla1 and End3; however, there was a gel mobility shift for Sla1 upon the 
addition of auxin (Figure 2.1D). This gel mobility shift of Sla1 was not seen in extracts 
from TIR1 cells treated with auxin, suggesting that the shift was due to the loss of Pan1, 
consistent with a predicted hyperphosphorylation phenotype (Figure 2.1E) (Zeng et al., 
2001; 2007). It has been proposed that auxin (specifically, indoleacetic acid (IAA)) can 
induce filamentous growth, adhesion, and/or growth arrest in WT cells; however, we did 
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Figure 2.1. Pan1-AID is an efficient tool for depleting Pan1 protein in cells. 
(A) Schematic of Auxin-Inducible Degron system for Pan1. (B) Serial dilutions of cells 
of indicated genotype were grown on synthetic media ± auxin for 3 d at 30°C. EV = 
empty vector. (C) Log phase cells were incubated in synthetic media ± auxin and the 
absorption at 600OD was measured every 30 min over 16hrs. (D-E) Immunoblots 
detecting Pan1, Sla1, and End3 in Pan1-AID (D) or TIR1 (E) cell lysates grown for 
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Degradation of Pan1 results in death of cells 
 To determine if the degradation of Pan1 led to either growth arrest or cell death, 
cells were grown the absence or presence of auxin and dead cells were stained with 
propidium iodide and quantified by flow cytometry. After 24 hours in the presence of 
auxin, Pan1-AID cells with EV reached almost 100% death, while death of the control 
strains was at similar levels to those with no auxin present (Figure 2.2A). To relate cell 
death to reduced Pan1 protein levels, cell death was analyzed over time. We found that 
Pan1-AID cells reach about 50% death after four hours in the presence of auxin, with 
over 75% of cells still alive between zero and two hours (Figure 2.2B). These early time 
points were used to assess the acute phenotypes of Pan1 depletion on living cells. The 
Pan1-AID death phenotype (Figure 2.2, A and B) was restored to WT levels with 
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Figure 2.2. Pan1 is required for viability
(A) Percentage of cells that were positively stained with propidium iodide (PI) after 
grown for 24 h ± auxin at 30°C was quantified by flow cytometry. Graph represents 
the average of three replicate experiments (Mean ± SD). (B) Strains were grown ± 
auxin and samples were collected at indicated times, stained with PI, and quantified by 
flow cytometry. Graph represents the average of three replicate experiments (Mean ± 
SD).
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Endocytosis is arrested in the absence of Pan1 
 Pan1’s most well characterized role in the cell is as an endocytic coat protein. 
Previous studies have shown that endocytosis is aberrant in pan1 mutant cells; thus, we 
hypothesized that endocytosis would be significantly affected in Pan1-AID cells upon 
depletion of Pan1 by the addition of auxin. We monitored bulk endocytosis using the 
lipophilic dye FM4-64 (Figure 2.3A). Cells were incubated in the absence and presence 
of auxin for 30 min and then stained with FM4-64 in similar auxin conditions for 15 min. 
In the control strains, WT and TIR1 plus EV, in the absence and presence of auxin and in 
Pan1-AID cells in the absence of auxin, the cells efficiently internalized the dye, which 
was trafficked throughout the cell, highlighting internal organelles such as endosomes 
and vacuoles. In contrast, FM4-64 was trapped at the plasma membrane in the Pan1-AID 
with EV cells plus auxin, indicating that bulk endocytosis had been arrested upon 
depletion of Pan1. This endocytic arrest was rescued by expressing full-length Pan1 from 
a plasmid.  
 To observe receptor-mediated CME, we used chimeras of the methionine 
permease Mup1 with pHlourin, a pH-sensitive variant of GFP (Miesenböck et al., 1998). 
In the absence of methionine in the growth medium, Mup1 is localized to the plasma 
membrane; upon addition of methionine, Mup1 is quickly endocytosed through CME and 
targeted to the vacuole lumen. The pHlourin signal is quenched in the acidic lumen of the 
late endosome/multivesicular bodies (MVB) and vacuoles. Thus, endocytic efficiency 
can be quantified by measuring the amount of fluorescence remaining after the addition 
of methionine (Prosser et al., 2010). In the absence of auxin, WT, TIR1, and Pan1-AID 





































































Figure 2.3. Bulk and receptor mediated endocytosis is arrested in Pan1-AID in the 
presence of auxin. 
(A) Representative images of log-phase cultures grown in ± auxin for 30 min before 
labeling with FM4-64 for 15 min. (B) Representative images of log-phase cultures ± 
pre-treatment with auxin for 30 min followed by addition of methionine for 1 h. Sche-
matic of Mup-pHl experimental timeline. (C) Quantification of Mup1-pHl fluorescence 
internalized after 30 min ± auxin pre-treatment and 1 h ± methionine. Percent Mup1-pHl 
internalized was calculated by measuring the amount of fluorescence at the end of the 
assay compared to the amount at the beginning. Graph represents average of three 
replicate experiments (Mean ± SD). Scale bar, 2μm. 
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B and C). The addition of auxin did not affect Mup1-pHl internalization for the control 
cells. However, when Pan1-AID cells were pre-treated with auxin for 30 min prior to the 
addition of methionine, Mup1 remained at the plasma membrane, again confirming that 
the absence of Pan1 causes an endocytic arrest. This arrest in endocytosis was fully 
rescued by expressing full length Pan1 from a plasmid in the Pan1-AID cells.  
 In the absence of both auxin and methionine, all strains exhibited brighter 
fluorescence at the plasma membrane over the time course. We hypothesize this is due to 
the continued production of Mup1-pHl that is trafficked to the plasma membrane. The 
addition of auxin alone appears to cause a decrease in Mup1-pHl fluorescence at the 
plasma membrane. The decrease in fluorescence does not appear to be due to endocytosis 
as there are no internal Mup1-pHl structures visible as is seen in cells that are competent 
for endocytosis. One possibility is auxin-dependent changes in cytosolic pH; however, 












Depletion of Pan1 does not cause a cell cycle arrest 
 The depletion of an essential protein can often lead to an arrest in cell cycle prior 
to death of the cells. In order to assess if Pan1-AID cells were arresting in a particular 
stage of the cell cycle prior to death, the DNA content of the cells at various time points 
after the addition of auxin was measured by staining DNA with propidium iodide. There 
was no observable difference between the amounts of cells with 1N or 2N DNA for WT, 
TIR1, and Pan1-AID cells in early time points (Figure 2.4, A and B). At the five-hour 
time point, a majority (75%) of Pan1-AID cells plus auxin were dead, which confounds 
the results at this time point. The absence of an arrest was confirmed by observing the 
cells under DIC where there was no obvious arrest of Pan1-AID cells in a particular stage 
of the cell cycle. Therefore, these data suggest that Pan1-AID cells are not arrested prior 


































































Figure 2.4 Pan1-AID cells do not arrest prior to cell death
(A and B) Strains were grown ± auxin and samples were collected at indicated times, 
fixed with ethanol overnight, stained with PI, and DNA content was quantified by flow 
cytometry: (A) percent of cells with 1N DNA content. (B) percent of cells with 2N DNA 
content. 
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Auxin-induced degradation of Pan1 is reversible  
 One of the benefits of the auxin-inducible degron system is the ability to wash-out 
the auxin to stop further degradation of the target protein and allow the cell to restore 
levels of newly synthesized protein. To test this in Pan1-AID cells, auxin was added to 
the cells for 2 hours, then cells were washed and the media was replaced with fresh media 
not containing auxin. Within one hour, expression of Pan1 protein was observed and cells 
began to grow (Figure 2.5, A and B). This confirms that, at least out to two hours, Pan1-




































Figure 2.5 Pan1 degradation and Pan1-AID cell growth are reversible after a 2 
hour auxin incubation. 
(A) Immunoblot detecting Pan1 in Pan1-AID cell lysates from cells incubated in ± 
auxin for 2 hours, washed, and incubated in fresh media without auxin. (B) Pan1-AID 
cells were grown in ± auxin and the OD600nm was measured at indicated times. Arrow 
indicates time at which wash step occured. 
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Sorbitol does not restore defects of Pan1 depletion  
 Endocytosis is a mechanism used for plasma membrane and cell wall 
homeostasis. Some endocytic mutants result in weak cell walls that burst due to osmotic 
pressure; addition of sorbitol to the media can help support these weak cells walls. 
Alternatively, sorbitol helps other endocytic mutants by reducing the turgor pressure that 
makes actin polymerization necessary. However, sorbitol was not able to restore growth 
or viability in the absence of Pan1 (Figure 2.6, A-C). While the cell wall may be 
weakened due to loss of Pan1, the addition of sorbitol is not able to inhibit the death 







































































Figure 2.6 Providing osmotic support to Pan1-AID cells in the presence of auxin 
does not restore growth or viability. 
(A) Serial dilutions of cells of indicated genotype were grown on synthetic media ± 
auxin, ± 1M sorbitol for 3 d at 30°C. (B) Log phase cells were incubated in synthetic 
media ± auxin, ± 1M sorbitol and the absorption at 600OD was measured every 30 min 
over 16hrs. (C) Strains were grown ± auxin +1M sorbitol and samples were collected at 
indicated times, stained with PI, and quantified by flow cytometry. 
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Cell death inhibitors do not rescue Pan1-AID cells 
 Although Pan1’s most well known function is in CME, CME itself is not an 
essential process, which begs the question of what is Pan1’s essential function? 
Determining how cells die in the absence of Pan1 may uncover what Pan1 is doing to 
maintain viability. Two well-known cell death inhibitors, rapamycin and cycloheximide, 
have been shown to inhibit cell death by either blocking the TOR pathway or inhibiting 
protein translation, respectively (Brown et al., 1994; Mattson and Furukawa, 1997; K. 
Cunningham, unpublished observations). However, neither drug was able to inhibit death 
of Pan1-AID cells in the presence of auxin, indicating that neither the TOR pathway nor 
protein translation is required for Pan1-AID cell death (Figure 2.7, A and B). 
Interestingly, cycloheximide did delay the death of cells by about 4 hours; this could 
mean that protein translation is required for the primary manner of death, but not 
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Figure 2.7. Death due to degradation of Pan1 is not dependent on the TOR pathway 
or protein translation. 
Log phase cells were incubated in synthetic media ± auxin, ± rapamycin (A) or ± cyclo-
heximide (B) and the absorption at 600OD was measured every 30 min over 16hrs (top) 



































Pan1-AID cells do not have any obvious differences of plasma membrane 
invaginations 
 To observe any gross phenotypes due to loss of Pan1 or addition of auxin, 
electron microscopy was performed on Pan1-AID cells after 0, 1 and 2 hours in the 
presence of auxin and compared to TIR1 cells plus auxin for 2 hours as a control. The 
number and length of plasma membrane invaginations increased with longer times in 
auxin (Figure 2.8, A and B). However, whether or not these invaginations correspond to 
CME sites, eisosomes, or some other type of invaginated structure is unknown. It has 
been observed that eisosomes may become exaggerated in endocytic mutants (Buser and 
Drubin, 2013). In Pan1-AID samples that were incubated for two hours in auxin, 10% of 
cells observed appeared very sick and/or dead (Figure 2.8C) which correlates with the 
death rate calculated in Figure 2.2B. All cells in the other samples had no obvious 
differences, suggesting that the addition of auxin alone was not deleterious to cells 

















































































































Figure 2.8. Gross morphologies of Pan1-AID and TIR1 cells incubated in auxin. 
(A and B) Quantification of the length (A) of invaginations and the number of invagina-
tions (B) per micron plasma membrane (PM) for each sample. N > 65 invaginations, N > 
30 cells. Images were collected and quantified blindly. Mean ±SD (C) Electron micro-
graph of a very sick/dead cell only seen in Pan1-AID plus auxin for two hours (10% of 
cells in that sample). (D) Electron micrographs of representative cells and invaginations 
from each sample. Boxed in area is magnified in image to the right of each cell. Scale 
bar, 1 μm. 
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DISCUSSION 
 Although much had been discovered about Pan1 using ts mutants and conditional 
expression of PAN1, these methods had caveats that left much unknown about Pan1’s 
specific mechanistic functions. The creation of Pan1-AID has allowed for a much more 
in-depth study of not only Pan1’s endocytic role, but also its essential function(s) and the 
regions of Pan1 that are critical in both of these roles.   
  In Pan1-AID cells, a majority of Pan1 protein is depleted within one hour after the 
addition of auxin, yet most cells remain viable; it requires four hours for over 50% of the 
cells to die (Figure 2.1D and 2.2B). How are Pan1-AID cells dying? CME is arrested 
after just one hour in the absence of Pan1 and although Pan1’s major role is in CME, 
CME is not essential and probably not the cause of cell death (Payne et al., 1988; Chu et 
al., 1996; Madania et al., 1999; Kaksonen et al., 2005; Newpher and Lemmon, 2006; 
Prosser et al., 2011)  
 The death of Pan1-AID cells was characterized in the hopes that discovery of how 
and why cells die in the absence of Pan1 could reveal Pan1’s essential function. Pan1-
AID cells do not arrest in a particular cell cycle stage prior to death and if auxin is 
washed out of the media after 2 hours, the cells will survive the brief period with minimal 
Pan1 levels (Figures 2.4 and 2.5). Thus, the death is not due to cell cycle disruption. 
Sorbitol can rescue several endocytic mutants by providing osmotic support to the cell 
wall or to reduce the necessity of actin polymerization; however, sorbitol did not restore 
growth or inhibit death of Pan1-AID cells in the absence of Pan1 (Figure 2.6). While this 
does not eliminate the possibility that loss of Pan1 results in cell wall or actin 
polymerization defects, these defects are not the primary cause of death.  
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 Some cell death pathways can be reversed using drugs to inhibit or delay the 
death pathways. The TOR pathway is one of the main cell death pathways and it can be 
inhibited with rapamycin. This drug does not inhibit Pan1-AID cell death, confirming 
that it is a TOR-independent death pathway (Figure 2.7, A and B). Cycloheximide, which 
inhibits protein translation, has been suggested to inhibit programmed cell death by down 
regulating the expression of “death genes” (Mattson and Furukawa, 1997). While 
cycloheximide did not inhibit Pan1-AID cell death, it did delay the death by about 4 
hours (Figure 2.7, C and D). Thus, protein translation may be important for the initial 
death pathway induced in the absence of Pan1, but not the entire, or secondary, death 
pathway.  
 Finally, death can be assessed by gross observation of the morphology of dead 
and dying cells. Electron micrographs of Pan1-AID cells after two hours in auxin showed 
that most cells looked similar to control cells (Figure 2.8D). The number and length of 
invaginations were similar between strains and auxin time points; however, whether or 
not these invaginations represent CME or other events has yet to be characterized (Figure 
2.8, A and B). A small percentage of cells did have large, ruptured vacuoles that filled the 
majority of the cell; these cells were most likely dead, or dying (Figure 2.8, C). 
Observing Pan1-AID cells at more time points after auxin addition should reveal more 
details about the mechanism of death.   
 Pan1-AID is a powerful tool that was used to acutely deplete cells of the essential 
protein Pan1. Using this tool, we confirmed that Pan1 is necessary for growth, viability, 
and endocytosis. Further work to uncover how Pan1 functions in each of these roles is 
necessary.   
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 Endocytosis is a well-conserved process by which cells invaginate small portions 
of the plasma membrane to create vesicles containing extracellular and transmembrane 
cargo proteins. Dozens of proteins and hundreds of specific binding interactions are 
needed to coordinate and regulate these events. There are several transitions during the 
process for which the exact mechanism of regulation is unknown: early coat maturation 
to late coat, coordination of actin regulators to actin machinery, and connection between 
the coat, membrane, and actin. Pan1 is thought to be a scaffolding protein due to its 
interactions with numerous proteins that act throughout the endocytic process and is 
therefore a prime candidate for regulation of these transition points. Previous research has 
characterized many Pan1 binding interactions, but due to Pan1’s essential nature, the 
exact mechanisms of Pan1’s function in endocytosis have been difficult to define.  Using 
the Pan1-AID degron strain (explained in Chapter 2), we characterized the how 
endocytosis is affected in the absence of Pan1. The loss of Pan1 caused an arrest in CME 
due to a delay in endocytic progression, aberrant interactions between actin machinery 










 Over 50 different proteins are involved in the initiation, maturation, and scission 
of endocytic events at the endocytic sites, or patches, and most of these proteins and their 
functions are well conserved between yeast and mammals. The formation of the clathrin 
coat, which consists of clathrin, adaptor proteins, coat proteins, and actin-regulatory 
complexes, begins with the recruitment of early coat proteins, such as Ede1 and Syp1, 
and adaptor proteins to the plasma membrane. The adaptors Yap1801/2 and Ent1/2 bind 
to cargo, late coat proteins, and clathrin, and connect the newly forming coat to the 
plasma membrane. Additional coat components, including Sla2, Sla1, End3, and Pan1 
associate at the endocytic site and recruit proteins for the final stages of endocytosis. 
Actin and actin regulatory proteins, such as Las17, Myo3/5, Arp2/3, and Sac6, are 
recruited to the site to invaginate the membrane and form the vesicle. Finally, the scission 
proteins Rvs161/167 complete the process by pinching off the newly formed vesicle from 
the plasma membrane, allowing the vesicle to be propelled into the cell through the force 
produced by actin polymerization. Through phosphorylation and dephosphorylation of 
both proteins and lipids, the clathrin coat dissociates from the vesicle and the proteins are 
recycled though the cytosol and back to the membrane to participate in further rounds of 
CME.  
 The yeast protein Pan1 is most well known as a CME coat protein that can 
interact with adaptors, early and late coat proteins, and actin regulatory proteins, thus 
Pan1 is presumed to act as a central scaffold that could link the early and late stages of 
endocytosis (Sachs and Deardorff, 1992; Wendland et al., 1996). Pan1 is a homolog of 
the mammalian protein Intersectin, which is also thought to be a CME scaffold as it also 
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binds several proteins involved throughout the endocytic process (Yamabhai et al., 1998; 
Hussain et al., 1999). Pan1 is a 1480 amino acid protein containing two N-terminal 
Eps15-homology (EH) domains, a central largely disordered region containing several 
predicted short coiled-coils, and a C-terminal actin regulatory domain.  
 Pan1 connects to the early coat through interactions found throughout the entire 
protein. Ede1 is one of the first proteins to arrive to an endocytic site and is thought to 
coordinate the initial steps of endocytosis; the C-terminus of Pan1 has been implicated in 
binding to the coiled-coil region of the early coat protein Ede1 (S. Barker and B. 
Wendland, unpublished observations). Next, adaptor proteins Yap1801/2 and Ent1/2 
arrive to the patch; Pan1 binds these adaptors through the well-conserved Eps15-
homology (EH) domains. Although Pan1 has two EH domains that are 72% similar, only 
the second domain can bind to EH ligands (Asn-Pro-Phe tripeptide motifs of the 
endocytic adaptor proteins Ent1/2 and Yap1801/2) (Salcini et al., 1997; Paoluzi et al., 
1998; Wendland and Emr, 1998; Wendland et al., 1999; Maldonado-Baez et al., 2008). 
Finally, Pan1’s central region can bind the adaptor/coat protein Sla2, which arrives to the 
patch slightly prior to Pan1 (Toshima et al., 2005; 2007).  
 Once the early coat proteins are at the patch and the initial steps of endocytosis 
are complete, the late coat proteins, including Pan1, are recruited to the patch. Pan1 can 
form homo-dimers and homo-oligomers (Miliaras and Wendland, 2004; Pierce et al., 
2013). Additionally, Pan1 forms a trimeric complex with two late coat proteins, Sla1 and 
End3, which bind its N-terminus and central region, respectively (Tang et al., 1997; 
2000; Whitworth et al., 2014). Throughout its N-terminus, Pan1 contains 19 Ark1/Prk1 
consensus phosphorylation sites; it has been proposed that phosphorylation negatively 
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regulates Pan1’s interactions with coat proteins and thus promotes dissociation of the coat 
from the vesicle (Zeng and Cai, 1999; Zeng et al., 2001; Toshima et al., 2005; 2007). 
However, recent evidence has shown that Pan1 and End3 remain tightly bound in the 
cytosol, thus phosphorylation may not affect this interaction (Boeke et al., 2014). Before 
recycling back to the plasma membrane for another round of endocytosis, Pan1 must be 
dephosphorylated by Glc7 (Zeng et al., 2007). 
 Lastly, Pan1 is involved with actin polymerization at the endocytic patch. Pan1 
binds F-actin and the type I myosins Myo3/5 through motifs in its C-terminal region 
(Duncan et al., 2001; Barker et al., 2007). Pan1 has a weak actin nucleating promoting 
activity through binding of the Arp2/3 complex (Toshima et al., 2005). However, Pan1 is 
not known to interact directly with the Wiskott-Aldrich syndrome protein (WASp) 
homolog, Las17, which is one of the strongest actin nucleating promoting factors at the 
patch (Li, 1997, Rodal et al 2003, Sun et al, 2006, Galletta et al, 2008). Pan1 and Las17 
do share several common binding partners, including Arp2/3, Myo3/5, and Sla1 (Tang et 
al, 1997, 2000; Toshima et al., 2005; Duncan et al., 2001; Barker et al., 2007; Feliciano 
and Di Pietro, 2012). Due to Pan1’s numerous interactions throughout the endocytic 
process, it is well suited to be key coordinator for maturation of the endocytic coat from 
early to late stages.  
 The timeline of recruitment of proteins to endocytic sites was determined by 
fluorescently tagging proteins and observing their localization and lifetimes at patches 
(Kaksonen et al., 2003). To characterize the endocytic role of a protein, the gene is 
deleted and the differences in the behavior of other fluorescently tagged proteins at the 
endocytic patch are observed. Upon deletion of late coat proteins, other coat proteins 
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have increased lifetimes at the endocytic patch, indicating an arrest or a stall in the 
pathway (Kaksonen et al., 2005). Additionally, actin polymerization is often aberrant, 
leading to increased or unregulated actin polymerization at the patch. Deletion of either 
Sla2 or the epsins Ent1 and Ent2 does not prevent the formation of endocytic patches, but 
it does halt the patch at the point of actin polymerization and causes an “uncoupling” 
between the forces resulting from actin polymerization and the subsequent changes of 
membrane shape (Kaksonen et al., 2003; Skruzny et al., 2012). In these mutants, short 
actin “comet tails” are anchored at the patch, but they are thought to be improperly 
attached to the membrane and thus the F-actin is unable to promote the invagination of 
the membrane to form a vesicle, ultimately inhibiting invagination of cargo. A distinct 
actin misregulation phenotype is seen with the double deletion of the Las17 inhibitors 
Bbc1 and Sla1 or Bbc1 and End3; Las17, the yeast homolog of WASP, is a strong Arp2/3 
activator and thus without Las17 inhibition, there a significant increase of actin 
nucleation at endocytic sites (Naqvi et al., 1998; Rodal et al., 2003). These deletions do 
not prevent the formation of patches, but the lifetime of coat proteins is increased and is 
accompanied by highly exaggerated Arp2/3 actin polymerization. Large plumes of F-
actin form at patches and extend far into the cell. In contrast to the Sla2/epsin deletes, the 
coat remains attached to both the membrane and actin, causing membrane to invaginate 
with the plumes, resulting in a successful endocytic event (Kaksonen et al., 2005).  
 Due to Pan1’s essential nature, deletion experiments to study the function of Pan1 
have not been possible. Previous work with Pan1 mutant alleles has suggested roles for 
Pan1 in endocytosis, actin cytoskeletal organization, polarized cell growth, and 
mitochondrial sorting (Zoladek et al., 1995; Tang and Cai, 1996; Wendland et al., 1996; 
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Bidlingmaier et al., 2001; Kamińska et al., 2005). However, its exact mechanistic role(s) 
in these pathways is unknown, nor is it known which of these, if any, is Pan1’s essential 
function(s). Pan1 binds early and late endocytic factors, thus we hypothesized that its 
deletion would cause misregulation of the recruitment and lifetimes of endocytic proteins 
at the patch. In addition, although Pan1 is itself not a strong regulator of actin 
polymerization, it does bind several proteins involved in actin regulation (both promotion 
and inhibition of actin polymerization) and therefore it is predicted that deletion could 
cause aberrant actin structures (Duncan et al., 2001; Toshima et al., 2005; Barker et al., 
2007). A Pan1 mutant allele, pan1-20, has a disrupted proline-rich domain (PRD); these 
cells had an increased number of invaginations, suggesting a misregulation of vesicle 
scission (Wendland et al., 1996; Barker et al., 2007). Pan1’s PRD interacts with Myo3/5, 
which have an increased lifetime at the patch in the pan1-20 strain (Barker et al., 2007). 
This indicates that the Pan1 PRD is not critical for Myo3/5 recruitment to endocytic sites, 
but without proper binding to Pan1, their function at the endocytic site is abnormal or 
delayed. While this Pan1 mutant allele provided some information about the function of 
Pan1 at the endocytic patch, it does not completely eliminate the function of Pan1; thus, 
experiments using a Pan1-degron strain were imperative to uncover all of Pan1’s roles at 
the patch.  
 In Pan1-AID, CME is quickly arrested and the progression between the early and 
late coat is delayed in the absence of the scaffolding function of Pan1. At the patches that 
did form, actin polymerization was aberrant, leading to the formation of dynamic actin 
flares containing coat components, but no invaginating membrane, suggesting a role for 
Pan1 in actin regulation and the coordination of coat interactions. 
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MATERIALS AND METHODS 
Media and Growth Conditions 
Yeast cells were grown in rich (yeast extract-peptone) or synthetic (yeast nitrogenous 
base with amino acids selection of plasmid maintenance) medium with 2% dextrose. For 
experiments using auxin in liquid cultures, 3-Indoleacetic acid (Sigma I2886) was added 
to synthetic media to a final concentration of 500µm. For experiments using auxin on 
solid media, 1-Naphthaleneacetic acid (Sigma N0640) was added to synthetic media to a 
final concentration of 1mM. Cycloheximide was added at a final concentration of 0.1M 
in indicated experiments.  
 
Strains and Plasmids 
The yeast strains and plasmids used in this study are listed in Tables 3.1 and 3.2, 
respectively. Strains were constructed using PCR-based genomic integration as described 
previously (Longtine et al., 1998; Goldstein and McCusker, 1999; Nishimura et al., 
2009). DNA manipulations for plasmid construction were preformed using standard 
techniques, employing either T4 DNA polymerase-mediated ligations in Escherichia coli 
or homologous recombination with overlapping DNA fragments followed by plasmid 
rescue in S. cerevisiae. All restrictions enzymes were purchased from New England 
Biolabs (Ispwich, MA).  
 
TABLE 3.1 Yeast strains used in this chapter 
Strain Genotype Source 
W303 













MATa his3-Δ200 trp1-Δ901 leu2-3,112 ura3-52 lys2-801 




MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA This Study 
BWY5394 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ADH1-OsTIR1-9myc::URA3 ade2::ADE2 HisΔ::URA 
Pan1-AID::G418 This Study 
BWY5890 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU This Study 
BWY5891 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU This Study 
BWY5892 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU This Study 
BWY6051 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Mup1-pHl::HPH This Study 
BWY6052 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU Mup1-pHl::HPH This Study 
BWY6053 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEUMup1-pHl::HPH This Study 
BWY6191 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Ent2-GFP::G418 This Study 
BWY6192 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU Ent2-GFP::G418 This Study 
BWY6193 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Ent2-GFP::G418 This Study 
BWY6146 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU YAP1801-GFP::G418 This Study 
BWY6147 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU YAP1801-GFP::G418 This Study 
BWY6148 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU YAP1801-GFP::G418 This Study 
BWY6054 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEURVS167-GFP::HPH This Study 
BWY6055 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU RVS167-GFP::HPH This Study 
64
BWY6056 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU RVS167-GFP::HPH This Study 
BWY6061 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Sla1-GFP::HPH Sac6-
RFP::G418 This Study 
BWY6062 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU Sla1-GFP::HPH Sac6-RFP::G418 This Study 
BWY6063 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Sla1-GFP::HPH Sac6-
RFP::G418 This Study 
BWY6111 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Sla2-GFP::HPH Sac6-
RFP::G418 This Study 
BWY6112 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU Sla2-GFP::HPH Sac6-RFP::G418 This Study 
BWY6113 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Sla2-GFP::HPH Sac6-
RFP::G418 This Study 
BWY6071 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU End3-GFP::HPH Sac6-
RFP::G418 This Study 
BWY6072 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU End3-GFP::HPH Sac6-RFP::G418 This Study 
BWY6073 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU End3-GFP::HPH Sac6-
RFP::G418 This Study 
BWY6190 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Sla1-GFP::HPH Sac6-
RFP::G418, prk1::NAT This Study 
BWY6206 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU Sla1-GFP::HPH Sac6-RFP::G418, 
prk1::NAT This Study 
BWY6207 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Sla1-GFP::HPH Sac6-
RFP::G418, prk1::NAT This Study 
BWY6286 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA This Study 
65
Pan1-AID::G418 Ade8Δ::LEU Sla2-GFP::HPH Sac6-
RFP::G418, ede1::NAT 
BWY6349 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1  can1-100 
ade2::ADE2 Ade8Δ::LEU Sla2-GFP::HPH Sac6-
RFP::G418, ede1::NAT This Study 
BWY6350 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA  
Ade8Δ::LEU Sla2-GFP::HPH Sac6-RFP::G418 ede1::NAT This Study 
BWY6412 
MATα his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 lys2Δ0 sla1::G418 
bbc1::G418 Sac6-RFP::HIS This Study 
 
 
TABLE 3.2 Plasmids used in this chapter 
Plasmid Details Description Source 
pBW373 pRS426::GFP-PH of PLCδ GFP-PH.426 Emr Lab 
 
Fluorescence microscopy 
GFP/RFP timelapse collections: 
Log phase cells were incubated with/without 500µM IAA for 45min-1 hr at 30°C and 
then imaged using the Zeiss AxioObserver Yokogawa CSU-X1 spinning disk confocal.  
Movies were captured with 150ms-200ms exposure, 0.5-4 seconds/frame for 90-120 
frames. Lifetimes of >50 individual patches for each strain were recorded and averaged 
together using ImageJ. Patch number per µm cell perimeter was counted for >30 
cells/strain and averaged using ImageJ. Representative kymographs were generated with 
Zen software.   
 
Image/Statistical Analysis 
Statistical significance between populations was determined by one-way ANOVA 





Endocytic patch initiation is independent of Pan1, while later steps require Pan1  
 To determine how CME is affected by the absence of Pan1, several known 
endocytic proteins were tagged with fluorescent markers and their patch dynamics were 
observed in the Pan1-AID strain after 45-60 min in the absence or presence of auxin. For 
all proteins tested, lifetimes and patch dynamics in control strains (WT and TIR1) in the 
presence and absence of auxin, as well as in Pan1-AID in the absence of auxin, were 
similar to previously published results (Tables 3.3 and 3.4, Figure 3.1, A and B) (Gagny 
et al., 2000; Kaksonen et al., 2003; 2005; Barker et al., 2007; Stimpson et al., 2009). This 
indicated that neither the addition of auxin, the AID tag, nor TIR1 affected endocytic 
dynamics when applied individually. Therefore, any patch number or lifetime 
discrepancies between Pan1-AID cells incubated in the presence or absence of auxin 
would suggest that Pan1 has a role in that protein’s recruitment and regulation at the 
endocytic patch. If a protein localized to the patch and had a similar patch lifetime in 
Pan1-AID cells plus auxin, this would indicate that Pan1 was not required for that 
protein’s recruitment and regulation at the patch.  
 
Pan1 is not required to initiate early events in endocytosis 
 We first present our findings pertaining to the proteins that arrive prior to Pan1 at 
the endocytic patch. In Pan1-AID plus auxin cells, Ede1-GFP was observed in patches 
that were stable for at least 6 min, the length of the image acquisition period (Tables 3.3 
and 3.4; Figure 3.1, C and D). In WT cells, Ede1-GFP binds and colocalizes with several 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.1 Endocytic proteins tagged with GFP have altered dynamics in Pan1-AID 
in the presence of auxin, but not in WT or TIR1 cells. 
Patch lifetime (sec) (A and C) and number of patches per micron of plasma membrane 
(B and D) of endogenously GFP and RFP-tagged proteins in WT and TIR1 cells (A and 
B)  and Pan1-AID cells (C and D) after 45-60 min ± auxin. Movies were taken with 
intervals of 0.5-4 s, 90-120 frames, with an exposure of 150 ms. Lifetimes: N > 50 
patches/strain, percent stable is number of patches that remained present for entire 
duration of image acquisition. Patch #: N > 30 cells/strain. Sac6-RFP is split into 
patches (P), flares (F), and total (T) Sac6-RFP structures. *P ≤ 0.001, **P ≤ 0.0001, 




































































the recruitment of actin (Gagny et al., 2000; Stimpson et al., 2009). In Pan1-AID plus 
auxin, Sac6-RFP actin patches and flares did not overlap with Ede1-GFP patches even 
though the Ede1 patches were stable, suggesting that the early and late coat may have 
become unlinked (Figure 3.1 and 3.2). The adaptor proteins Yap1801 and Ent2 both 
arrive to the patch prior to Pan1 and bind to Pan1’s second EH domain (Wendland and 
Emr, 1998; Wendland et al., 1999). In Pan1-AID plus auxin, Yap1801-GFP and Ent2-
GFP had increased lifetimes relative to controls, and 26% or 50% of patches, 
respectively, remained stable for the duration of image acquisition (Tables 3.3 and 3.4; 
Figure 3.1, C and D).  
 Sla2, a coat/adaptor protein, is thought to arrive slightly prior to Pan1 at the patch 
and binds several endocytic proteins including Pan1’s central region (Toshima et al., 
2007). In Pan1-AID plus auxin, Sla2-GFP had an increased lifetime relative to controls, 
with 44% of patches remaining stable for the duration of image acquisition (Table 3.3 
and 3.4, Figure 3.1 and 3.2). Although Sla2-GFP was recruited to patches, there were 
slightly fewer Sla2-GFP patches in the presence of auxin (Table 3.4; Figure 3.1D). 
Similar to WT cells, Sla2-GFP patches that were not stable moved in with the patch 
(Figure 3.2A).  
 
Late arriving proteins are present at fewer patches and have extended lifetimes in the 
absence of Pan1 
 The remaining coat and actin proteins we observed all arrive at endocytic patches 
at the same time or after Pan1 in WT cells. In Pan1-AID plus auxin, Sla1, End3, Las17, 
Myo5, Rvs167, and Sac6 had decreased numbers of patches and all except Rvs167 had 
71































Figure 3.2 Endocytic proteins have longer lifetimes and late arriving proteins have 
fewer patches in Pan1-AID cells in the presence of auxin
(A) Representative kymographs of GFP-tagged proteins and Sac6-RFP in Pan1-AID cells 
grown in ± auxin for 45-60 min. All kymographs are oriented with cell interior at the 
bottom. Kymographs made from movies used for quantification in Figure 3.1. (B) 














increased lifetimes at the patch relative to controls (Tables 3.3 and 3.4, Figure 3.1, C and 
D). Previous work has shown a decrease in patch number and an increase in Myo5 
lifetime upon deletion of Pan1’s PRD to which Myo5 binds (Barker et al., 2007). Sla1, 
End3, and Myo5 bind Pan1, but they localized to endocytic patches in the absence of 
Pan1, so their localization to patches must depend on their interactions with other 
proteins and/or the membrane (Tang et al., 1997; 2000; Barker et al., 2007; Whitworth et 
al., 2014). Las17 and Rvs167 are not known to bind Pan1 directly and they were also 
able to localize independently of Pan1. In patches that did not result in actin flares (see 
below), Sla2, Sla1, and End3 internalized with the patch while Myo5, Las17, and Rvs167 
remained at the plasma membrane in a manner comparable to a wildtype endocytosis 
event.   
 
Actin flares that contain late coat proteins, but not membrane, form in the absence 
of Pan1 
 Pan1’s C-terminus is thought to contribute to actin polymerization at endocytic 
patches via several actin-regulatory domains and direct binding to F-actin (Duncan et al., 
2001; Toshima et al., 2005). In Pan1-AID cells plus auxin we observed a significant 
decrease in the number of actin patches (Sac6-RFP was used to label branched F-actin); 
those that formed had an increased lifetime and some patches had the appearance of 
elongated structures of polymerized actin which were named “actin flares” (Tables 3.3 
and 3.4; Figure 3.1, C and D, Figure 3.3, Movies 1-3). These actin flares originated from 
an endocytic patch and extended into the cytoplasm, sometimes flowing parallel to the 
















































































































































































































































































































actin flare. To visualize plasma membrane dynamics in relation to the actin flares, we 
used GFP-pleckstrin homology domain chimeras (GFP-PH), which bind the PI(4,5)P2 
lipids found in abundance on the plasma membrane. As a control, we confirmed that 
GFP-PH does label internalized membrane in synaptojanin mutants as seen in previous 
work (Figure 3.4A) (Stefan et al., 2002). The Pan1-AID actin flares did not contain 
membrane (Figure 3.4, B and C), suggesting the coat/actin machinery has weakened 
connections to the membrane. The actin flares also did not contain internalized 
transmembrane cargo (Figure 3.4D). These flares differed from the aberrant actin 
phenotypes observed previously in other endocytic mutants. The actin-uncoupling 
phenotype observed in sla2Δ or ent1/2Δ cells is characterized by short actin comet tails 
anchored at the plasma membrane that do not invaginate the plasma membrane or coat 
components (Kaksonen et al., 2003; Skruzny et al., 2012). In contrast, the uncontrolled 
Arp2/3 actin plumes seen in sla1Δ/bbc1Δ or end3Δ/bbc1Δ cells are long and contain 
invaginated plasma membrane with coat components at the tip (Figure 3.4C) (Kaksonen 
et al., 2005). In Pan1-AID plus auxin, the actin flares were not stable at patches, 
contained the coat components Sla2, Sla1, and End3, but did not contain membrane 
(Figure 3.3 and 3.4). The Pan1-AID actin flares were longer than the sla2Δ or ent1/2Δ 
actin comet tails, but not as elongated as the actin plumes seen in sla1Δ/bbc1Δ or 
end3Δ/bbc1Δ. It is known that Pan1 binds several actin regulators, such as the Las17 
inhibitor Sla1 and the Arp2/3 activators Myo3 and Myo5 (Tang et al., 2000; Duncan et 
al., 2001; Toshima et al., 2005; Barker et al., 2007). Our data suggest that Pan1 may be 































































































































































































































































































































proper linkage of the coat to the membrane in order transmit the force of actin 
polymerization needed to invaginate the membrane (Figure 3.5).  
 To briefly summarize our findings in Pan1-AID cells plus auxin, the endocytic 
factors that arrive prior to Pan1 (Ede1, Ent2, Yap1801, and Sla2) had longer lifetimes, 
with some of the patches remaining stable for the duration of the data collection period 
(Table 3.3 and Figure 3.1, C and D). The CME components that arrive at the same time 
or after Pan1 (Sla1, End3, Las17, Myo5, Rvs167, and Sac6) also had increased lifetimes 
whereas, unlike the earlier arriving proteins, they had decreased patch numbers (Tables 
3.3 and 3.4; Figure 3.1, C and D). Overall, longer lifetimes and fewer late coat patches 
suggested inefficient progression of the endocytic patch to later stages and fewer 
productive endocytic events. The most dramatic phenotypic difference observed in the 
Pan1-AID strain in the presence of auxin (relative to the absence of auxin), was a 
significant decrease in the number of Sac6-RFP patches and the appearance of actin 
flares as labeled by Sac6-RFP (Figure 3.3). These flares contained late coat proteins, but 
not membrane or transmembrane cargo, and are thus thought not to be successful sites of 












Figure 3.5 Sla2/Epsins and Pan1 strengthen critical interactions between mem-
brane, coat, and actin in CME.
(A) Schematic of the final steps of CME in WT and Pan1-AID, + auxin cells. 
(B) Model of Pan1 and Epsins/Sla2 interactions with the plasma membrane, endocytic 
coat, and actin machinery. EpsinΔ/Sla2Δ and Pan1-AID phenotypes shown in red. 
Dashed arrow represents binding between Pan1 and lipids (D. Pierce and B. Wendland, 












Deletion of Pan1 kinase, Prk1, in Pan1-AID cells does not restore growth or 
endocytic defects 
 Through phosphorylation and dephosphorylation of both proteins and lipids, the 
clathrin coat dissociates from the vesicle and proteins are recycled through the cytosol 
and back to the membrane to participate in further rounds of CME. Pan1 is heavily 
phosphorylated by the evolutionarily conserved protein kinases Ark1/Prk1, which is 
thought to negatively regulate Pan1’s interactions with other coat proteins to promote 
dissociation of the endocytic protein coat (Zeng and Cai, 1999; Zeng et al., 2001; 
Toshima et al., 2005; 2007). To allow reuse at endocytic patches, Pan1 is 
dephosphorylated by Glc7 (Zeng et al., 2007). Deletion of PRK1 in a wild-type 
background results in the appearance of large cytosolic clumps of actin, but deletion in a 
pan1-4 background rescues actin cytoskeletal defects (Cope et al. 1999; Zeng and Cai, 
1999).  However, prk1Δ does not restore the viability of a pan1Δ strain, suggesting that 
Prk1 does not play a role in Pan1’s essential function (Zeng and Cai 1999). Therefore, we 
hypothesized that deletion of PRK1 in the absence of Pan1 would not restore growth, but 
may restore some of the endocytic defects. Pan1-AID, prk1Δ cells were not able to grow 
in the presence of auxin (Figure 3.6A). Although the lifetimes of Sac6-RFP patches were 
slightly longer in prk1Δ cells, the number of patches did not change and actin clumps 
were observed in both conditions (Figure 3.6, B and C). These data indicate that Prk1 
does not have a role in Pan1’s essential condition, but may help Pan1 regulate the 










































Figure 3.6 Deletion of Prk1 does not restore defects caused by loss of Pan1.
(A) WT and prk1Δ cells were streaked onto plates ± auxin and grown for 3 d at 30°C. 
(B) Number of Sac6-RFP patches per micron plasma membrane and (C) lifetime (sec) 
in Pan1-AID and Pan1-AID, prk1Δ cells incubated for 1 ± auxin. Movies were taken 
with intervals of 1000s, 120 frames, with an exposure of 150 ms. Patch #: N > 30 











- Auxin + Auxin
80
Remaining endocytic patches do not likely contain remnant Pan1 protein 
 While the AID system does deplete targeted protein quickly, at the one-hour time 
point there may be some residual Pan1-AID protein remaining in the cell. This remaining 
pool of protein may localize and function at endocytic patches prior to being degraded, 
aiding the small percentage patches that mature and internalize normally. If this residual 
protein is eliminated, we hypothesized that the delayed maturation phenotypes we 
observed would be exacerbated in the complete absence of Pan1. If mature endocytic 
patches still form in the complete absence of Pan1, this indicates that endocytic patches 
can mature independently of Pan1, but at a severely reduced rate. To eliminate remaining 
Pan1-AID protein, endocytic patches were observed after 2 hours in the presence of 
auxin. At this time point, Pan1 protein is undetectable by western blot and about 10% of 
cells are dead (Figure 2.1D and 2.2B). After 2 hours in the presence of auxin, Sla1-GFP 
localizes to patches in similar numbers to 1 hour plus auxin (Figure 3.7A). However, the 
lifetime of Sla1-GFP increases even more than it did after 1 hour (Figure 3.7B). This 
suggests that after 1 hour, some Pan1 may be at the patches to help the coat mature, but 
once this pool of Pan1 is reduced even further, the lifetimes increase. Therefore, Sla1 
does not depend on Pan1 to localize to patches, but it does require Pan1 to regulate its 
lifetime at the patch.  
 In AID experiments, Pan1-AID is continuously translated before being recognized 
by TIR1 and degraded. To eliminate this newly translated Pan1-AID protein pool, 
cycloheximide was added at the same time as auxin to shut-off all protein translation 
while degrading all previously synthesized Pan1-AID protein. Cycloheximide alone did 





















Figure 3.7 Incubating Pan1-AID cells in auxin for 2 hours does not exacerbate 
Sla1-GFP patch number or lifetime phenotype
(A) Number of Sla1-GFP patches per micron plasma membrane and (B) lifetime (sec) 
in Pan1-AID cells incubated for 1 or 2 hours ± auxin. Movies were taken with intervals 
of 1000s, 120 frames, with an exposure of 150 ms. Patch #: N > 30 cells/condition. 



















were reduced as compared to cells without auxin or cycloheximide (Figure 3.8, A and B). 
In the presence of auxin and cycloheximide, End3-GFP patch numbers were reduced 
similar to numbers observed in the absence of cycloheximide, and the lifetime increased. 
The lifetime of End3-GFP in the presence of auxin and cycloheximide was slightly 
reduced compared to auxin alone, but the trend was similar. In the presence of auxin and 
cycloheximide, mature endocytic patches containing late coat proteins were still 
observed, suggesting that these patches do not contain residual Pan1-AID protein (Figure 
3.8). Therefore, these data, along with Figure 3.7, confirm that Pan1 is not necessary for 
late coat maturation, but it is critical for proper efficiency of this transition.  
 
Endocytic patches are still able to form in the absence of two key endocytic 
regulators  
 Recent work implicated the early coat protein Ede1 as a critical coordinator for 
the early stages of endocytosis (Boeke et al., 2014). It was suggested that the coiled-coil 
region of Ede1 needed to bind to an unknown late coat protein for proper maturation of 
the patch. Unpublished work from our lab found that the coiled-coil region of Ede1 binds 
to Pan1’s N-terminus (S. Barker and B. Wendland). In the absence of Ede1, early arriving 
proteins have reduced or altered patch numbers, while later arriving proteins, including 
Sla2, Sla1, Las17, Ent1/2, have decreased lifetimes and decreased patch numbers 
(Kaksonen et al., 2005; Reider et al., 2009; Stimpson et al., 2009; Carroll et al., 2012). It 
was hypothesized that removal of both Ede1 and Pan1 would further exacerbate the 
endocytic defects seen in the individual mutants and perhaps inhibit all endocytic patches 




























Figure 3.8 Cycloheximide does not exacerbate the phenotype of the absence of 
Pan1.
(A) Number of End3-GFP patches per micron plasma membrane and (B) lifetime (sec) 
in Pan1-AID cells incubated for 60 min ± auxin and ± 0.1M cycloheximide. Movies 
were taken with intervals of 1000s, 120 frames, with an exposure of 150 ms. Patch #: N 
> 30 cells/condition. Lifetimes: N > 50 patches/condition. Mean ± SD. * = P < 0.05, ** 























presence of auxin (Figure 3.9A). In Pan1-AID ede1Δ cells, Sla2-GFP was able to localize 
to patches, but with altered dynamics as compared to Pan1-AID and ede1Δ alone (Figure 
3.9, B and C). Both in the presence and absence of auxin, Pan1-AID ede1Δ cells had 
fewer Sla2-GFP patches than Pan1-AID cells in the absence of auxin, but there was no 
difference in the lifetime. This decrease in Sla2 patch number in the absence of Ede1 has 
been previously reported in the literature (Stimpson et al., 2009). However, in Pan1-AID 
ede1Δ cells, Sla2-GFP patches did not further decrease in patch number or increase in 
lifetime with the addition of auxin, as seen in Pan1-AID cells. Thus, deletion of EDE1 
restored the Sla2 localization and lifetime defects due to absence of Pan1. This suggests 
that Ede1 and Pan1 may function together to coordinate the transition between early and 
























- Auxin + AuxinA.
Figure 3.9 Deletion of EDE1 partially restores defects due to absence of Pan1.
(A) WT and ede1Δ cells were streaked onto plates ± auxin and grown for 3 d at 30°C. 
(B) Number of Sla2-GFP patches per micron plasma membrane and (C) lifetime (sec) in 
Pan1-AID and Pan1-AID ede1Δ cells incubated for 1 ± auxin. Movies were taken with 
intervals of 1000s, 120 frames, with an exposure of 150 ms. Patch #: N > 30 
cells/condition. Lifetimes: N > 50 patches/condition. Mean ± SD. *P ≤ 0.05, **P ≤ 0.01, 











































 An individual CME event requires the temporal and spatial coordination of 
hundreds of interactions between many different proteins. Each event can be temporally 
separated into stages: early, late, actin polymerization, and scission. Endocytic proteins 
are classified according to the stage of endocytosis they arrive to the patch. Pan1 stands 
out among endocytic proteins because it interacts with numerous proteins throughout all 
stages of endocytosis, making Pan1 an ideal candidate as a scaffold to hold the coat 
together as it transitions between stages (Sachs and Deardorff, 1992; Wendland et al., 
1996). However, the exact mechanism of Pan1’s function in endocytosis has never been 
fully realized due to experimental challenges. Pan-AID provided a unique opportunity to 
deduce Pan1’s mechanisms of endocytic regulation and to characterize endocytosis in the 
absence of Pan1. 
 In Pan1-AID cells in the presence of auxin, both bulk and receptor-mediated 
endocytosis were arrested (Figure 2.3). The phenotypes of the dynamics of endocytic 
proteins in the absence of Pan1 can be clearly separated into the early and late stages of 
endocytosis. The early coat proteins localize with WT efficiency to patches, but their 
lifetimes are significantly extended and many patches are stable (Tables 3.3 and 3.4, 
Figure 3.1). Therefore, Pan1 is not required to initiate endocytic sites but is important for 
coat maturation. The few late coat patches that did form had extended lifetimes. The 
decrease in the number of late coat protein patches could either be the result of the 
individual proteins having a reduced binding efficiency and/or an overall decrease in the 
number of endocytic patches that mature to later stages. If the latter were true, this would 
implicate Pan1 as a critical regulator of the transition from early to late coat, where Pan1 
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coordinates and strengthens the interactions that are crucial for the early coat proteins to 
link with late coat proteins (i.e., Ede1-Pan1, Syp1-Las17, Sla2-late coat proteins and 
actin).  
 To rule out the possibility of un-degraded Pan1-AID protein functioning at these 
remaining mature patches, two experiments were performed to eliminate residual Pan1 
protein: extension of time in auxin to degrade more Pan1-AID protein and addition of 
cycloheximide to inhibit protein translation. Late coat patches were found in both 
conditions in comparable numbers to the one hour in auxin condition, confirming that 
these late coat patches could form in the absence of Pan1 (Figures 3.7 and 3.8). 
Therefore, while Pan1 is not absolutely required for maturation to late coat, it is a very 
critical component for efficient endocytosis.  
 Abnormal actin polymerization phenotypes are commonly seen in endocytosis 
mutants (Kaksonen et al., 2003; 2005; Skruzny et al., 2012). Although Pan1’s direct role 
in actin regulation may be small, its indirect role in the coordination of other actin 
inhibitors and regulators is important (Duncan et al., 2001; Toshima et al., 2005; Barker 
et al., 2007). In the absence of Pan1 we observed significantly fewer actin patches, some 
of which developed dynamic actin flares that contain late coat proteins, but do not 
invaginate membrane or transmembrane cargo (Figures 3.1- 3.4). These flares represent a 
distinct “in-between” phenotype relative to the previously described actin comet tails and 
actin plumes of other endocytic mutants (Kaksonen et al., 2003; 2005; Skruzny et al., 
2012). We hypothesize that in the absence of Pan1, early acting inhibitors of Arp2/3/actin 
polymerization, such as Syp1 and Sla1, cannot properly engage Las17. This leads to 
increased Arp2/3 actin polymerization that resembles sla1Δ/bbc1Δ actin plumes 
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(Kaksonen et al., 2005). And, similar to Sla2 we propose that Pan1 is critical for coupling 
the membrane to the coat/actin machinery in order to transmit the forces of actin 
polymerization to invaginate the membrane (Figure 3.4) (Kaksonen et al., 2003; Skruzny 
et al., 2012).   
 Past results have shown that deletion of the Pan1 kinase Prk1 can restore actin 
cytoskeletal defects in a Pan1 mutant background, but cannot restore the growth defects 
of a pan1Δ strain (Zeng and Cai 1999). Deletion of PRK1 did not rescue growth or 
endocytic defects caused by the absence of Pan1 (Figure 3.6). Thus, phosphorylation of 
Pan1 may be important for Pan1’s actin regulatory role, but not its general endocytic or 
essential functions. 
 Recent work identified Ede1 as an organizer of the initiation of endocytosis and 
suggested that Ede1’s coiled-coil region binds unknown late coat protein(s) (Boeke et al., 
2014). Ede1’s homolog, Eps15, binds Intersectin through its coiled-coil region, similar to 
our unpublished work that found that Pan1 binds to Ede1’s coiled-coil region (Sengar et 
al., 1999; Wong et al., 2012, S. Barker and B. Wendland, unpublished observations). 
Together, this strongly suggests that Pan1 and Ede1 are likely to work together to 
mediate endocytic progression from early to late stages. In the absence of Ede1, Sla2 
patches have shorter lifetimes and fewer patches; in the absence of Pan1, Sla2 patches 
have increased lifetimes and fewer patches; and in absence of both, Sla2 has fewer 
patches with wild-type lifetime (Figure 3.9B) (Stimpson et al., 2009). Thus, ede1Δ 
partially restores the defects due to the absence of Pan1. In reference to the lifetime, Ede1 
may be important for the arrival of Sla2 to the patch, thus in the absence of Ede1, Sla2 
arrives later, resulting in a shorter lifetime. Pan1 is important for the mid-to-late stages of 
89
Sla2’s lifetime, thus in the absence of Pan1, Sla2 patches have a longer lifetime. In the 
absence of both Ede1 and Pan1, Sla2 may both arrive later and leave later, resulting in a 
lifetime that appears normal, but is actually shifted later in the timeline of CME. 
Therefore, this confirms that proper coat maturation depends on both Ede1 and Pan1 for 
coordination of the early, middle, and late stages of CME.  
 Our study of Pan1 confirmed that Pan1 is an essential endocytic scaffold that 
regulates the interactions important for transitions between endocytic stages: the early 
coat to the late coat, actin regulatory proteins to actin machinery, and the membrane to 
the coat/actin machinery (Figure 3.5). Further studies are required to determine which 
regions of Pan1 are important for its endocytic role (discussed in Chapter 4) and what 






CHAPTER 4: DEFINING THE REGIONS OF PAN1 






























Some of the work presented in this chapter is published at Molecular Biology of the Cell 





 Pan1 is a large protein that has several known conserved binding domains, 
including two Eps15-homology domains (EH), coiled-coiled regions, an F-actin binding 
domain, and a proline-rich domain. The central region of Pan1 has remained elusive due 
to the experimental difficulties of working with an unstructured amino acid sequence. All 
previous work defining Pan1’s regions has been completed using Pan1 mutant alleles that 
depend on temperature sensitivity; a variable that can alter endocytic phenotypes. 
Additionally, the work has all been done in reference to Pan1’s role in CME, leaving 
little to no evidence of which regions are important for Pan1’s essential role. Thus, a 
complete, unbiased, study of Pan1 regional functionality for CME and viability is needed 
to determine which interactions and motifs are important for either function and whether 
or not these functions could be separated.  
 By expressing various regions of Pan1 on single-copy plasmids in Pan1-AID, it 
was determined which regions of Pan1 are crucial for its various functions. We identified 
a region of Pan1 spanning the second EH domain and central region that was critical for 
viability and endocytosis. Additionally, we defined regions of Pan1 that supported 
viability and not endocytosis, suggesting Pan1 may have an additional role(s) 








 Pan1 and its mammalian homolog, Intersectin, are both large proteins that contain 
several binding sites enabling them to interact with numerous proteins throughout the 
endocytic process, thus giving rise to their characterization as scaffolding proteins (Sachs 
and Deardorff, 1992; Wendland et al., 1996, Yamabhai et al., 1998; Hussain et al., 1999). 
Much has been done to define the various regions, motifs, and binding sites within the 
proteins; however, due to their essential nature, a more careful definition of their 
functions was technically difficult, if not impossible, in the past. The development of the 
Pan1-AID strain allows, for the first-time, the ability to observe the contribution of each 
region and motif of Pan1 in live cells.  
 Pan1 is a 1480 amino acid protein containing two N-terminal Eps15-homology 
(EH) domains, a central largely disordered region containing several coiled-coils, and a 
C-terminal actin regulatory domain. The N-terminus is made up of two long repeat 
regions (LR1 and LR2) that each contain an EH domain. The two EH domains are 72% 
similar, yet only the second domain can bind to EH ligands (Asn-Pro-Phe (NPF) 
tripeptide motifs of the endocytic adaptor proteins Ent1/2 and Yap1801/2) (Salcini et al., 
1997; Paoluzi et al., 1998; Wendland and Emr, 1998; Wendland et al., 1999; Maldonado-
Baez et al., 2008). Pan1 forms a complex with Sla1 and End3, which bind its N-terminus 
and central region, respectively (Tang et al., 1997; 2000; Whitworth et al., 2014). 
Through its central region, Pan1 can form homodimers and homo-oligomers and binds 
the coat protein Sla2 (Miliaras and Wendland, 2004; Toshima et al., 2005; 2007; Pierce 
et al., 2013). In addition, it has been proposed that the central region contains three 
nuclear localization signals (NLS) and a lipid-binding region (Kamińska et al., 2007, D. 
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Pierce and B. Wendland, unpublished results). Pan1 regulates actin polymerization 
through motifs in its C-terminal region, which bind F-actin and the type I myosins 
Myo3/5 (Duncan et al., 2001; Barker et al., 2007). Through binding the Arp2/3 complex, 
the C-terminus has a weak actin nucleating promoting activity (Toshima et al., 2005). 
The C-terminus has also been implicated in binding to the coiled-coil region of the early 
coat protein Ede1 (S. Barker and B. Wendland, unpublished observations). Additionally, 
Pan1 is phosphorylated by the evolutionarily conserved protein kinases Ark1/Prk1 
through 19 consensus phosphorylation sites; it has been proposed that this 
phosphorylation negatively regulates Pan1’s interactions with other coat proteins and thus 
promotes dissociation of the coat from the vesicle (Zeng and Cai, 1999; Zeng et al., 2001; 
Toshima et al., 2005; 2007). Before recycling back to the plasma membrane for another 
round of endocytosis, Pan1 must be dephosphorylated by Glc7 (Zeng et al., 2007). Due to 
Pan1’s numerous interactions throughout the endocytic process, it is well suited to be a 
key coordinator for maturation of the endocytic coat from early to late stages. 
 Recent work with Pan1 containing mutated or deleted EH domains found that 
Pan1’s EH domains are not critical for patch formation or efficient endocytosis, but may 
be important for the patch lifetime regulation of some coat proteins (Suzuki et al., 2011). 
The mild phenotype of these mutant alleles is most likely due to the redundancy of EH 
domains in End3 and Ede1, which are also found at endocytic patches. In fact, when all 
EH domains in these three proteins are mutated, endocytic efficiency is significantly 
decreased. In these EH mutants, early coat proteins, such as Syp1, had a similar number 
of patches but with an increased lifetime, while late coat proteins, such as Abp1, had a 
decreased number of patches and a similar lifetime to WT. These data suggest that while 
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patches can form in the absence of functional EH domains, there is a decreased success 
rate of endocytic internalization.  
 The Pan1-AID strain is an ideal system to test the functional important of the 
various Pan1 regions and domains. Previous attempts to define regions depended on 
plasmid shuffling experiments in a pan1Δ background strain; thus these experiments 
were limited to study of portions of Pan1 that could support viability (Sachs and Deardorf 
1992, Miliaras et al., 2004, Duncan et al., 2001, Suzuki et al., 2012). In Pan1-AID, full-
length Pan1-AID protein was acutely depleted within one hour by the addition of auxin, 
allowing characterization of the functionality of the plasmid-expressed Pan1 fragment. 
Using this method, it was determined that the C-terminal actin-regulatory region of Pan1 
is not critical for patch localization, CME, or viability. Portions of N-terminus and central 
region were necessary for localization, CME, and viability. Additionally, two fragments 
were found that restore viability, but not CME, suggesting they may function in Pan1’s 











MATERIALS AND METHODS 
Media and Growth Conditions 
Yeast cells were grown in rich (yeast extract-peptone) or synthetic (yeast nitrogenous 
base with amino acids selection of plasmid maintenance) medium with 2% dextrose. For 
experiments using auxin in liquid cultures, 3-Indoleacetic acid (Sigma I2886) was added 
to synthetic media to a final concentration of 500µm. For experiments using auxin on 
solid media, 1-Naphthaleneacetic acid (Sigma N0640) was added to synthetic media to a 
final concentration of 1mM.  
 
Strains and Plasmids 
The yeast strains and plasmids used in this study are listed in Tables 4.1 & 4.2, 
respectively. Strains were constructed using PCR-based genomic integration as described 
previously (Longtine et al., 1998; Goldstein and McCusker, 1999; Nishimura et al., 
2009). DNA manipulations for plasmid construction were preformed using standard 
techniques, employing either T4 DNA polymerase-mediated ligations in Escherichia coli 
or homologous recombination with overlapping DNA fragments followed by plasmid 
rescue in S. cerevisiae. All restrictions enzymes were purchased from New England 
Biolabs (Ispwich, MA).  
 
TABLE 4.1 Yeast strains used in this chapter 
Strain Genotype Source 
BWY5892 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU This Study 
BWY6232 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Sac6-RFP::G418 This Study 
BWY6422 MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1- This Study 
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100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Ade8Δ::LEU Sla1-GFP::HPH Sac6-RFP::G418 
end3::NAT 
BWY6423 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Sla1-GFP::HPH Sac6-
RFP::G418 end3::NAT This Study 
BWY6502 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU Mup1-pHl::HPH 
end3::NAT This Study 
BWY6564 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 can1-
100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 HisΔ::URA 
Pan1-AID::G418 Ade8Δ::LEU, end3::NAT This Study 
 
TABLE 4.2 Plasmids used in this chapter 
Plasmid Details Description Source 
pRS414 CEN, TRP1   
Laboratory 
plasmid 
pBW626 pRS414::PAN1 (CEN, TRP1) pPan1.414 





pPan1 AA: 1-97, 
390-1480.414 




TRP1) pPan1 AA: 1-855.414 
Sachs et al., 
1992 
pBW1438 
pRS414::pan1 W312A W642A 
(CEN, TRP1) pPan1-EH1/2.414 
Laboratory 
plasmid 

















855.414 This study 
pBW2535 
pRS414::pan1 (AA250-855 
W312A) (CEN, TRP1) 
pPan1 AA: 250-855 
EH1.414 This study 
pBW2537 
pRS414::pan1 (AA250-855 W312A 
W642A) (CEN, TRP1) 
pPan1 AA: 250-855 
EH1/2.414 This study 
pBW2550 
pRS415::pan1 (AA402-1050 
K/RàE) (CEN, LEU2) 
pPan1 AA: 402-1050 
K/RàE.415 This study 
pBW2551 
pRS415::pan1 (AA402-1050 
K/RàE) (CEN, LEU2) 
pPan1 AA: 402-1050 






























pPan1 AA: 1-97, 
402-855.414 This study 
pBW2618 
pRS414::pan1 (AA250-855 
W642A) (CEN, TRP1) 
pPan1 AA250-855 















GFP.414 This study 
pBW2627 
pRS414::pan1(AA1-97, 402-855)-
GFP (CEN, TRP1) 
pPan1 AA: 1-97, 
402-855-GFP.414 This study 
pBW2629 
pRS414::pan1(AA1-97, 402-855 
W642A) (CEN, TRP1) 
pPan1 AA: 1-97, 




pPan1 AA: 1-390, 





855.414 This study 
pBW2667 pRS414::pan1-15TA (CEN, TRP1) pPan1-15TA.414 This study 
pBW2670 
pRS414::pan1(AA402-1050 
K/RàE) (CEN, TRP1) 
pPan1 AA:402-1050 
K/RàE.414 This study 
pBW2671 
pRS414::pan1-K/RàA (CEN, 
TRP1) pPan1 K/RàA This study 
pBW2673 
pRS414::pan1(AA402-1050 
K/RàA) (CEN, TRP1) 
pPan1 AA:402-1050 
K/RàA.414 This study 
pBW2675 
pRS414::pan1 (250-855 15TA) 
(CEN, TRP1) 
pPan1 AA:250-855 
15TA.414 This study 
pBW2679 
pRS414::pan1 (402-1050 15TA) 
(CEN, TRP1) 
pPan1 AA:402-1050 




pPan1 AA: 1-401, 





1050.414 This study 
pBW2779 
pRS414::pan1 (AA402-1050 
W642A) (CEN, TRP1) 
pPan1 AA: 402-1050 










pPan1 AA: 1-97, 
680-1480.414 This study 
pBW2795 
pRS414::pan1(AA1-702) (CEN, 





GFP.414 This study 
pBW2814 
pRS414::pan1 W312A W642A-
GFP (CEN, TRP1) 
pPan1-EH1/2-
GFP.414 This study 
pBW2815 
pRS414::pan1 (1-97, 402-855 
W642A)-GFP (CEN, TRP1) 
pPan1 AA: 1-97, 
402-855 EH2-
GFP.414 This study 
pBW2817 
pRS414::pan1 (250-855 W312A)-
GFP (CEN, TRP1) 
pPan1 AA: 250-855 
EH1-GFP.414 This study 
pBW2818 
pRS414::pan1 (250-855 W642A)-
GFP (CEN, TRP1) 
pPan1 AA: 250-855 
EH2-GFP.414 This study 
pBW2819 
pRS414::pan1 (250-855 W312A 
W642A)-GFP (CEN, TRP1) 
pPan1 AA: 250-855 
EH1/2-GFP.414 This study 
pBW2841 
pRS414::pan1(AA1-401, 856-
1480)-GFP (CEN, TRP1) 
pPan1 AA:1-401, 
856-1480-GFP.414 This study 
pBW2842 
pRS414::pan1 W312A-GFP (CEN, 
TRP1) pPan1-EH1-GFP.414 This study 
pBW2844 
pRS414::pan1(AA1-401, 856-1480 
W312A)-GFP (CEN, TRP1) 
pPan1 AA:1-401, 
856-1480 EH1-
GFP.414 This study 
pBW2911 
pRS414::pan1 (402-1050 W642A)-
GFP (CEN, TRP1) 
pPan1 AA: 402-1050 




TCA Precipitation:  
Mid to late-log phase cells -/+ Auxin at indicated time points were harvested and 
resuspended in 1ml of 10% trichloroacetic acid (TCA) with 1mM 4-(2-
aminoethyl)benzenesulfonyl fluoride (AEBSF, a protease inhibitor), incubated on ice for 
20 min, and precipitates were centrifuged at 14,000 rpm for 10 min at 4°C. Precipitates 
were washed twice with cold acetone, resuspended by sonication, and air-dried. Protein 
samples were processed for SDS-PAGE separation by adding 2x protein sample buffer 
with 1mM AEBSF and solubilized by bead disruption.  
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SDS-PAGE and Immunoblotting: 
Proteins were separated on polyacrylamide mini gels (7.5%) at 27mA in SDS running 
buffer (3mM SDS, 25mM Tris base, 192mm glycine) and then transferred onto 
nitrocellulose membranes at 80V for 90 min in cold transfer buffer (20% methanol, 
0.0375% SDS, 48mM Tris base, 30mM glycine). The membranes were blocked in 5% 
milk in TBST (10mM Tris, pH 7.5, 0.25M NaCl, 0.025% Tween-20). Blots were 
incubated in the specified primary antibody overnight at the following concentrations: 
Rabbit-anti-Pan1 was a gift from D.G. Drubin and was used at 1:10,000; Rabbit-anti-GFP 
is from Molecular Probes and was used at 1:5,000. The blots were washed 3 times in 
TBST, incubated with secondary antibodies conjugated to HRP (Pierce, Rockford, IL) 
diluted 1:2,000 in milk solution for 45 min. Blots were washed again 3 times in TBST, 
and then developed with chemiluminescent substrate (Solution 1:2.5mM Luminol, 
400uM paracoumaric acid, 100mM Tris-HCl, pH 8.5. Solution 2: 5.4mM H2O2, 100mM 
Tris-HCl, pH 8.5) for 2 min at room temperature. Chemiluminescence images were 
acquired using a FluorChem M FM0455 imager.  
 
Growth Assays 
Serial Dilutions: Log phase cells were diluted to OD600 of 0.25, from which four 1:5 
serial dilutions were plated on YNB-tryptophan minus or plus 1mm NAA and grown for 
three days at 30°C.  
 
Propidium Iodide Staining 
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Aliquots of cells from each culture were taken at the indicated times after incubation in 
minus or plus 500µm IAA at 30°C and labeled with 1µg/ml propidium iodide. 5,000 cells 
were immediately analyzed on a BD FACS-Calibur (Becton Dickinson & Co., Mountain 
View, CA) flow cytometry system to quantify the population of cells with fluorescent 




Mup1-pHlourin images were collected using a Zeiss Axiovert 135TV inverted 
microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY) with a Sensicam QE CCD 
camera (Cooke, Romulus, MI), Zeiss 100x 1.4 NA Plan-Apochromat objective, 
motorized filter wheels, fluorescein isothiocynate (FITC) and Texas Red filter sets 
(Semrock, Rochester, NY), and Slidebook 5.0 software (Intelligent Imaging Innovations, 
Denver, CO). Images were captured with 500ms exposure, identical binning, 
intensification and illumination intensity. For quantification of fluorescence intensity, 16-
bit image files were analyzed in Image J v1.41n. Background subtraction was performed 
before measurement of integrated density, and values were corrected for cell size.  
 
To perform kinetic analysis of endocytosis, cells expressing Mup1-pHlourin were grown 
overnight in synthetic YNB media lacking methionine (YNB-met). Cells were then 
diluted to a density of 0.35 OD/ml in YNB-met, and were grown to a density of 0.6 
OD/ml. Cells were then seeded onto concanavalin A-coated 8-well glass-bottomed 
chamber slides (LabTek, Scotts Valley, CA) containing YNB-Met and were allowed to 
101
settle before imaging. Cells were/were not treated with 500µM IAA for 30 min, then 
methionine was added at a concentration of 20µg/ml and images were captured after 30 
min or one hr. During image acquisition, cells were maintained at a constant temperature 
of 30°C. Experiments with Pan1 plasmids were performed in YNB-trp-met media.  
 
GFP/RFP timelapse collections: 
Log phase cells were incubated with/without 500µM IAA for 45min-1 hr at 30°C and 
then imaged using the Zeiss AxioObserver Yokogawa CSU-X1 spinning disk confocal.  
Movies were captured with 150ms-200ms exposure, 0.5-4 seconds/frame for 90-120 
frames. Lifetimes of >50 individual patches for each strain were recorded and averaged 
together using ImageJ. Patch number per µm cell perimeter was counted for >30 
cells/strain and averaged using ImageJ. Representative kymographs were generated with 
Zen software.   
 
Image/Statistical Analysis 
Statistical significance between populations was determined by one-way ANOVA 









Regions of Pan1 important for localization to the endocytic patch 
Pan1’s central region is critical for localization and stabilization at endocytic patches  
 We predicted that Pan1 must localize to the patch in order to perform its 
endocytic function. We identified the regions of Pan1 that are critical for proper Pan1 
localization to the endocytic patch by C-terminally tagging Pan1 fragments with GFP and 
observing their localization. Pan1 binds several other endocytic proteins, some of which 
arrive to the patch before Pan1 and may recruit Pan1. Pan1 also binds itself, so by 
expressing the fragments in the Pan1-AID strain in the absence and presence of auxin, we 
were able to determine if the presence of full-length Pan1 was necessary for proper 
localization of the fragments (Miliaras and Wendland, 2004; Toshima et al., 2005; Pierce 
et al., 2013). All Pan1 fragments used expressed protein of expected size in both the 































































































































































































































































































































Anti-Pan1 #92 (epitope: AA1079-1125)
Anti-Pan1 #91 (epitope: AA391-680)
Pan1AA: Pan1AA:
Pan1AA:Pan1AA:
Figure 4.1 All plasmids used in this study express protein of expected mass.
(A-F) Immunoblots detecting Pan1 in cell lysates of Pan1-AID cells containing indi-
cated plasmids grown at 30°C ± auxin for 2 h.
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 All Pan1-GFP fragments tested were able to localize to endocytic patches in the 
absence and presence of auxin except for Pan1AA402-855-GFP and Pan1AA1050-1480-
GFP (Figure 4.2). This confirmed that the C-terminal actin regulatory region of Pan1 was 
not necessary for localization, and also could not localize to patches without the in cis 
support of the central region. The N-terminal (Pan1AA1-702-GFP) and central region 
(Pan1AA702-1050-GFP) were individually sufficient to localize to the patches. Both the 
N-terminal and central regions of Pan1 have endocytic binding partners that arrive before 
or at the same time as Pan1 to patches, suggesting these interactions may be important for 
Pan1’s recruitment to patches.   
 In the absence of auxin, Pan1-GFP fragments had a decreased patch number and 
lifetime compared to full-length Pan1. Upon removal of full-length Pan1 by the addition 
of auxin, all Pan1-GFP fragments (except Pan1AA702-1050-GFP) trended toward more 
patches; this increase was statistically significant for Pan1AA1-855-GFP, AA250-855-
GFP, and AA402-1050-GFP (Figure 4.2). This suggests that these fragments were 
competing with full-length Pan1 for binding at the patch. The lifetimes of all fragments 
also increased in the presence of auxin; this may be due to either decreased competition 
with full-length Pan1 and/or an overall increase in endocytic patch lifetime observed in 
Figure 3.1C.  
 Although a majority of Pan1 fragments were able to localize to endocytic patches, 
some had significantly decreased lifetimes at the patch compared to full-length Pan1 
(Figure 4.2B). There are several interpretations for the shortened lifetimes, one of which 
is that these fragments are missing key binding elements that strengthen Pan1’s 

















































































































































402-1050 402-855 1-97, 402-855 1-401, 856-1480250-855
C.
Figure 4.2 Pan1’s central region is critical for localization to endocytic patch.
(A) Number of Pan1-GFP patches per micron plasma membrane in Pan1-AID strain ± 
auxin for 1 h. No patches were observed for Pan1 AA1050-1480-GFP and 
Pan1AA402-855-GFP. N > 30 cells/strain. (B) Lifetime (s) of GFP-tagged proteins at 
endocytic patch in Pan1-AID cells ± auxin for 1 h. (C) Representative images of Pan1-
AID cells plus indicated Pan1-GFP fragments grown in the presence of auxin for 1 h. *P 
≤ 0.01, **P ≤ 0.0001 minus vs. plus auxin (Mean ± SD).
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for Pan1 fragment stabilization/lifetime at the patch, as highlighted by the dramatic 
difference in lifetime and patch number between Pan1AA1-702 and Pan1AA1-855/1050. 
Although Pan1AA1-702-GFP and Pan1AA1-855/1050-GFP can both localize to patches, 
AA1-702-GFP had a significantly shorter lifetime, suggesting that Pan1AA703-855/1050 
contains a patch stabilizing property. However, the central region alone, Pan1AA702-
1050-GFP, also had a short lifetime, indicating that this region required another Pan1 
region for normal temporal behavior. Additional N- or C-terminal sequences appended to 
the Pan1AA702-1050-GFP fragments increased its lifetime, but only the addition of the 
N-terminus increased the lifetime to WT levels. Therefore, the N-terminal and central 
regions together restore normal lifetime dynamics of Pan1 at endocytic patches.  
  In conclusion, the central region (Pan1AA702-1050) alone was sufficient for 
Pan1 localization to the endocytic patch, but the N-terminus was needed to ensure Pan1 












Regions of Pan1 important for endocytosis 
Pan1’s EH domains and central region are necessary for its endocytic function 
 In the absence of full-length Pan1, endocytosis was arrested (Figure 2.3). We 
identified the regions of Pan1 necessary for its endocytic role using the Mup1-pHl assay 
with Pan1 fragments in the Pan1-AID strain. After pretreatment with auxin for 30 min, 
methionine was added to induce internalization of Mup1-pHl and cells were observed one 
hour later. If a Pan1 fragment contained all regions necessary for endocytosis, Mup1-pHl 
would be efficiently internalized and the cells would be dim, similar to cells with full-
length Pan1. However, if a Pan1 fragment could not support endocytosis, Mup1-pHl 
would remain at the plasma membrane and the cells would be bright, similar to Pan1-
AID cells with EV. In the case where an intermediate brightness value of the population 
was obtained, there are two potential explanations. First, there may be a mixture of cells 
with Mup1-pHl at the plasma membrane, in endosomes or MVBs, or dim in the vacuole, 
part of which may be due to heterogeneous expression of plasmids from cell to cell. 
Alternatively, this could be due to all the cells having an overall intermediate brightness. 
When quantified for percentage of Mup1-pHl internalized, these samples would have 
values between those seen for EV and for full-length Pan1. An intermediate phenotype is 
indicative of slow or inefficient endocytosis, suggesting the fragment only partially 
restored endocytosis.  
 Similar to results for Pan1 localization, efficient Mup1-pHl internalization 
required Pan1’s central region supported by portions of the N-terminus; the C-terminal 
actin region was not required (Figure 4.3). It was previously thought that Pan1’s first EH 





























































Figure 4.3 Pan1’s EH domains and central region are important for its endocytic 
function.
(A) Quantification of the amount of Mup1-pHl fluorescence internalized after 30 min ± 
auxin pre-treatment and 1 h ± methionine. Percent Mup1-pHl internalized was calcu-
lated by measuring the amount of fluorescence at the end of the assay compared to the 
amount at the beginning. Graph represents average of three replicate experiments. 
Mean ± SD. (B) Representative images of Pan1-AID strains plus indicated plasmids 
after 30 min plus auxin and 1 h plus methionine. Percentage is average Mup1-pHl 
internalized calculated in (A). Scale bar, 2μm. 
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and was found to be dispensable for viability (Sachs and Deardorff, 1992; Wendland and 
Emr, 1998; Wendland et al., 1999). Surprisingly, we found that the first EH domain 
could in fact support endocytosis in the absence of EH2, as Pan1AA1-390, 680-1490 
internalized most Mup1-pHl (Figure 4.3). However, when both EH domains were deleted 
as in Pan1AA1-97, 680-1480, Mup1-pHl was not internalized. Although the N-terminus 
of Pan1 (Pan1AA1-702) could localize to endocytic patches, this region was unable to 
promote internalization of Mup1-pHl. Extending the fragment to include some of the 
central region (Pan1AA1-855) restored the endocytic function, further confirming Pan1’s 
central region as critical for Pan1’s localization and function at the endocytic patch. 
Additionally, we defined a region of Pan1, AA402-855, that was necessary, but not 
sufficient, for endocytosis, as Pan1AA1-401, 856-1480 and AA402-855 did not 
internalize Mup1-pHl. This region spans the EH2 domain and some of the central region. 
Interestingly, adding to this AA402-855 fragment either the rest of the central region 
(Pan1AA402-1050) or the N-terminus (Pan1AA1-855) restored the endocytic function. 
Pan1AA250-855, which includes both EH domains, only barely restored endocytosis (as 
seen by the punctae present in Figure 5E), while the far N-terminal portion of LR1 
(Pan1AA1-97, 402-855) did not promote internalization of Mup1-pHl at all. These data 
suggest that Pan1AA402-855 is critical for CME, but it requires LR1 (including EH1) or 
the rest of the central region for full endocytic function.  
 In summary, Pan1AA402-855, which contains EH2 and a portion of the central 
region, was critical for endocytic function and patch formation and requires either LR1 or 
the central region for full restoration of endocytic defects.  
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Regions of Pan1 that restore viability 
Pan1 contains three overlapping minimal essential fragments that localize to patches, but 
only one restores endocytosis  
 Pan1 is an essential protein whose primary role is in CME, which is not thought to 
be an essential process; therefore, this raises the questions of what is Pan1’s essential role 
and can it be separated from its role in endocytosis. To explore these questions, the 
essential regions of Pan1 were defined by expressing fragments of Pan1 on plasmids in 
Pan1-AID cells and observing which fragments restored growth and viability in the 
presence of auxin. Pan1 AA402-855 is necessary, but not sufficient for growth or 
viability; this “minimal” essential region requires the addition of one of three regions of 
Pan1: AA250-401, AA856-1050, or AA1-97 to rescue growth and viability (Figure 4.4). 
The minimal region contains the second EH domain as well as a portion of the central 
region that is important for Pan1-Pan1 binding and Pan1-End3 binding. Pan1’s C-
terminal actin-regulatory region is not essential for viability, confirming data from the 
literature (Duncan et al., 2001). 
 In addition, we found that Pan1’s first EH domain could support growth in the 
absence of the second EH domain (and vice versa), contradicting previous results (Figure 
4.4) (Sachs and Deardorff, 1992). This disparity was resolved by our finding that the 
original plasmid encoding Pan1AA: 1-390, 680-1480 does not express protein. Adaptor 
proteins have only been shown to bind the second EH domain; however, our data suggest 
that either adaptor proteins can interact with the first EH domain, or these interactions 




































































































- Auxin + Auxin
Figure 4.4 Pan1 contains three overlapping minimal essential regions.
(A) Serial dilutions of Pan1 fragments grown ± auxin for 3 d at 30°C. * = Pan1 frag-
ment is C-terminally GFP tagged, ** = both GFP and untagged versions of Pan1 frag-
ment are used in experiments, both grow similarly in ± auxin. (B) Percentage of Pan1-
AID cells with indicated Pan1 plasmids that were positively stained with PI after grown 
for 24 h ± auxin at 30°C was quantified by flow cytometry. Graph represents the aver-
age of three replicate experiments. Mean ± SE.
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 All Pan1 fragments tested that did not support growth also did not restore viability 
of the Pan1-AID strain in the presence of auxin (Figure 4.4B). The essential regions of 
Pan1 partially restored viability, but the increased death suggests that the cells are in a 
compromised state, perhaps due to partial loss of Pan1’s non-essential function.  
 In summary, Pan1’s minimal common region, AA402-855, is critical for its 
localization and stability at the endocytic patch and necessary for Pan1’s endocytic and 
essential roles (Figure 4.5). This common minimal region requires additional Pan1 
regions to stably localize to endocytic patches (Pan1AA1-97, AA250-401, or AA856-
1050), restore endocytosis (Pan1AA1-401 or AA856-1050), or support cell viability 
(Pan1AA1-97, AA250-401, or AA856-1050). The exact mechanism of action that each of 
these three additional regions contributes to the common minimal region is currently 
under investigation. Of the Pan1 fragments tested, all fragments that did not support 
growth also did not restore endocytosis or viability. Pan1AA1-855 and Pan1AA402-1050 
are the minimal regions necessary for endocytosis, but the mechanism of how either the 
addition of the LR1 and LR2 or the remaining central region function to restore 
endocytosis is unknown. Potential explanations are that the Sla1 binding site in LR1 and 
the lipid-binding activity in the central region could be critical for Pan1’s endocytic 
functions (Tang et al., 2000, D. Pierce and B. Wendland, unpublished results). Two 
fragments, Pan1AA1-97, 402-855 and Pan1AA250-855 supported growth, but were not 
able to fully restore endocytosis of Mup1-pHl, suggesting that either: 1) these fragments 
support a basal level of bulk endocytosis, but not endocytosis of the specific cargo or, 2) 























































































































































































































































































































































































































































































































































































































































Regions of Pan1 important for actin regulation 
 The contribution of Pan1 fragments to endocytic patch formation was observed 
with Sac6-RFP in Pan1-AID cells expressing various Pan1 fragments (both GFP-tagged 
and untagged) in the presence of auxin. All Pan1-GFP fragments arrived to the patch 
prior to Sac6-RFP, similarly to full-length Pan1. As summarized previously for Pan1-
AID cells, in the presence of auxin there was a decrease in Sac6-RFP patch numbers and 
Sac6-RFP actin flares were observed (Figure 3.1 and 3.3). In contrast, no actin flares 
were seen in the presence of Pan1-GFP or untagged Pan1 fragments, suggesting that 
these fragments all contain some portion of Pan1 that is able to directly or indirectly 
regulate actin polymerization (Figure 4.6). However, Pan1AA1-97, 390-1480; AA1-390, 
680-1480; AA1-855; AA1-1050; and AA402-1480 were able to rescue the decreased 
Sac6-RFP patch number phenotype. All of these fragments contain a portion of the N-
terminus and central region, again confirming their importance for Pan1 function. 
Additionally, these data also indicated that the C-terminal actin regulatory region of Pan1 
is neither necessary nor sufficient for Sac6-RFP dynamics at the endocytic patch. This 
implies that Pan1’s role in actin regulation may be more indirect through its interactions 
















































































































* * * *
Figure 4.6: Pan1’s N-terminus and central region are necessary for actin patch 
formation.
 (A) Number of Sac6-RFP patches per micron plasma membrane in Pan1-AID cells plus 
indicated plasmid. Cells were incubated in auxin for 45-60min before imaging. N > 30 
cells/strain. *P ≤ 0.0001 vs. full-length Pan1 (1-1480). Mean ± SD.
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At least one Pan1 EH domain is necessary to support growth, localization, and 
endocytosis in minimal Pan1 fragments 
 Pan1 contains two EH domains within the two N-terminal LR regions; these EH 
domains contain well-conserved binding pockets for NPF motif containing proteins 
(Paoluzi et al., 1998). Recent work indicated that Pan1’s EH domains are not necessary 
for endocytosis due to the redundancy of EH domains present in Ede1 and End3 (Boeke 
et al., 2014). We confirmed these results by mutating the tryptophan in both Pan1 EH 
domains in full-length Pan1 and found that this construct was able to restore growth and 
endocytosis to Pan1-AID cells in the presence of auxin (Figure 4.7, A and B). However, 
due to the evidence in my previous results that indicates at least one EH domain is 
important for endocytosis, I tested the necessity of each EH domain in the context of the 
minimal essential fragments. Pan1 AA1-97, 402-855 and 402-1050 each contain only the 
second EH domain; when the NPF binding pocket is mutated, these regions can no longer 
support growth, but this mutation did not affect the ability of AA402-1050 to restore 
endocytosis. AA402-1050 contains most of the central region, which is also critical for 
endocytosis, so perhaps the presence of the central region helps support endocytosis. 
Pan1 AA250-855 contains both EH domains. Interestingly, mutation of each individual 
EH domain only slightly decreases restoration of growth and endocytosis in Pan1-AID, 
while mutation of both EH domain renders the fragment useless for both growth and 
endocytosis. This again confirms that at least one EH domain and some of the central 
region is necessary for Pan1 to support endocytosis.  
 Presumably, localization to the endocytic patch is required for Pan1 to support 
endocytosis. To test the necessity of the EH domains for localization to the patch, Pan1 
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Figure 4.7 At least one Pan1 EH domain is necessary for growth, CME, and local-
ization in minimal Pan1 fragments
(A) Serial dilutions of Pan1 fragments expressed in Pan1-AID cells grown ± auxin for 3 
d at 30°C. (B) Quantification of the amount of Mup1-pHl fluorescence internalized after 
30 min ± auxin pre-treatment and 1 h ± methionine. Percent Mup1-pHl internalized was 
calculated by measuring the amount of fluorescence at the end of the assay compared to 
the amount at the beginning. Mean ± SD. (C) Number of Pan1-GFP patches per micron 
plasma membrane (left) and lifetime in seconds (right) in Pan1-AID strain ± auxin for 1 
h. Absence of bar indicates no patches formed. N > 30 cells/strain for patch number, N> 
20 patches/strain for lifetime. 
EH1 = W312A mutation, EH2 = W642A mutation, EH1/EH2 = W312A and W642A 
mutations. 
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fragments containing mutations in the NPF-motif binding pocket of EH1, EH2, or both 
EH domains tagged with GFP were observed in Pan1-AID cells in the absence and 
presence of auxin. In full-length Pan1, mutation of either the first or both EH domains did 
not affect localization of Pan1 (Figure 4.7C). The NPF-motif binding pocket is also not 
necessary for localization and lifetime in Pan1AA402-1050. However, at least one, wild 
type, EH domain is necessary for localization and lifetime in the context of the other two 
minimal fragments. Mutation of either EH1 or EH2 in AA250-855 decreased the patch 
number and lifetime, and mutation of both EH domains completely disrupted 
localization. In AA1-97, 402-855, mutation of the only EH domain present, EH2, 
disrupted localization.  
 These results suggest that the NPF-motif binding pocket does somewhat 
contribute to Pan1 patch localization and endocytosis in the context of the minimal 
fragments, but it is redundant with other regions that are present in full-length and 
Pan1AA402-1050. One possible region that could be critical for localization is the lipid-
binding region. Interestingly, the Pan1AA402-1050 W642A mutant fragment can restore 
CME and localize to patches, but does not restore viability; once again confirming that 







Lipid binding region of Pan1 is critical for growth and endocytosis in minimal 
essential fragments 
 Previous work in our laboratory found a lipid-binding region in the central portion 
of Pan1 (D. Pierce and B. Wendland, unpublished observations). This region spanning 
AA1020-1040 is a basic patch that contains ten positively charged lysines and arginines 
and resembles the PI4,5P2 consensus sequence (Yu et al., 1992). Mutating seven of these 
lysines and arginines to glutamic acid (negative) or alanine (neutral) is predicted to 
maintain secondary structure while abolishing lipid binding (D. Pierce and B. Wendland, 
unpublished observations). Mutation to negatively charged amino acids was predicted to 
be a more severe mutation as this would repel the region from lipids, while the neutral 
mutation simply disrupts binding. In the context of full-length Pan1, either mutation did 
not interfere with growth or endocytosis. However, in the minimal fragment of AA402-
1050 these mutations led to loss of restoration of both growth and endocytosis (Figure 
4.8). Thus, the lipid-binding region is necessary for growth and endocytosis in the 
minimal Pan1 fragment. This fragment may be important for localization or lifetime of 
Pan1 at the endocytic patch. The region may also be important for Pan1’s essential 
function(s).  
 It is important to note that this lipid-binding region overlaps with a predicted NLS 
region (Kaminska et al., 2007). When four of the ten lysines were mutated to asparagine 
(neutral, uncharged), a reporter protein was unable to localize to the nucleus; however, 
this work was never confirmed in vivo in the context of full-length Pan1. Two of these 
lysines are mutated in our binding mutants; thus, our lipid-binding mutants may also be 
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Figure 4.8 Pan1 lipid-binding domain is essential for growth and endocytosis in 
minimal Pan1 fragment
(A) Serial dilutions of Pan1 fragments expressed in Pan1-AID cells grown ± auxin for 3 
d at 30°C. K/R→E = 7 lysines/arginines mutated to glutamic acid, K/R→A = 7 
lysines/arginines mutated to alanine. (B) Quantification of the amount of Mup1-pHl 
fluorescence internalized after 30 min ± auxin pre-treatment and 1 h ± methionine. 
Percent Mup1-pHl internalized was calculated by measuring the amount of fluorescence 
at the end of the assay compared to the amount at the beginning. Mean ± SD.
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disrupting the putative NLS region. Further experiments are needed to refine these 
regions and their functions.   
 
Pan1 phosphorylation sites are not necessary for growth or endocytosis  
 Cycles of phosphorylation and dephosphorylation are critical for recycling 
endocytic proteins between internalization events. Pan1 contains 19 Ark1/Prk1 
phosphorylation consensus sites throughout its N-terminus. Mutation of 15 of these sites 
from threonine to alanine mimics the phenotype seen in ark1Δ/prk1Δ cells, which are 
characterized by the presence of large clumps of actin in the cytosol and a slight defect in 
cell growth (Cope et al., 1999; Toshima et al., 2005). It was proposed that 
phosphorylation of Pan1 negatively regulates its interactions with other coat proteins and 
F-actin, as well as inhibiting its activation of Arp2/3 actin polymerization (Zeng et al., 
2001, Toshima et al., 2005). However, it was not know if these phosphorylation sites are 
critical for CME and/or viability.  
 Using plasmids that encode fragments of Pan1 on plasmids that have 15 of the 
Ark1/Prk1 phosphorylation sites mutated in Pan1-AID cells, it was confirmed that these 
sites are not necessary for restoration of growth in full-length Pan1, nor are they 
necessary for endocytosis (Figure 4.9). These sites do not become essential for growth or 
endocytosis in the context of the minimal fragments. Thus, it appears that Ark1/Prk1 
phosphorylation of these 15 sites is not important for Pan1’s endocytic or essential 
function; whether or not the other 4 sites or any unknown phosphorylation sites 


























































Figure 4.9 Ark1/Prk1 phosphorylation of Pan1 is not necessary for growth or endo-
cytosis
(A) Serial dilutions of Pan1 fragments expressed in Pan1-AID cells grown ± auxin for 3 
d at 30°C. * = 15TA mutation. (B) Quantification of the amount of Mup1-pHl fluores-
cence internalized after 30 min ± auxin pre-treatment and 1 h ± methionine. Percent 
Mup1-pHl internalized was calculated by measuring the amount of fluorescence at the 
end of the assay compared to the amount at the beginning. Mean ± SD.
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End3 interactions with Pan1 
 As discussed in previous results, the first few hundred amino acids of the central 
region of Pan1 is necessary for all tested functions. This region contains a binding site for 
another late coat protein, End3, as well as regions implicated in Pan1 homo-dimers and 
homo-oligomers (Miliaras et al., 2004; Pierce et al., 2013; Whitworth et al., 2014). The 
Pan1-End3 interaction is stable both at the patch and in the cytosol and is no longer 
thought to be regulated by phosphorylation as previously suggested (Zeng et al., 2001; 
Toshima et al., 2007; Boeke et al., 2014). This suggests that the Pan1-End3 interaction is 
important, but is the central region that we found critical due to the End3 interaction or 
the Pan1 interaction (or both?). Do the minimal Pan1 fragments depend on the presence 
of End3 to localize and function at the endocytic patch or restore viability? To test this, 
END3 was deleted in the Pan1-AID strain background and Pan1 fragments were tested 
for their ability to function in the absence of End3. Deletion of END3 alone results in 
slow growth and a severe CME defect (Whitworth et al., 2014). In the Pan1-AID end3Δ 
strain in the presence of auxin, only full-length Pan1 was able to restore growth, 
indicating that the minimal Pan1 fragments rely on the presence of End3 to function 
(Figure 4.10A). In Mup1-pHl experiments, Pan1-AID end3Δ plus EV plasmid has 
severely reduced CME due to the loss of end3 and this CME defect is exacerbated by the 
loss of Pan1 (Figure 4.10B). When a Pan1 plasmid is added in the absence of auxin, the 
two copies of Pan1 protein are able to slightly increase CME efficiency in Pan1-AID 
end3Δ cell, but this increase is lost upon loss of Pan1-AID protein in the presence of 
auxin.  
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Figure 4.10 Pan1 essential fragments rely on End3 for viabilty and localization.
(A) Pan1-AID end3Δ cells containing indicated plasmids were streaked onto plates ± 
auxin and grown for 4 d at 30°C. (B) Representative images of Pan1-AID,end3Δ strains 
plus indicated plasmids after 30 min ± auxin and 1 h plus methionine. (C) Number of 
Pan1-GFP patches per micron plasma membrane in Pan1-AID end3Δ cells  ± auxin for 1 
hr. Absence of bar indicates no patches formed. 


















































































 Pan1 and End3 arrive and leave the endocytic patches in similar time frames. Loss 
of END3 results in significantly increased Pan1 lifetimes (Whitworth et al., 2014). In the 
absence of Pan1, there were fewer End3 patches and those patches had longer lifetimes, 
suggesting that End3 may depend on Pan1 for patch localization and lifetime regulation 
(Figure 3.1D). Pan1-GFP fragments were observed in Pan1-AID end3Δ cells in the 
absence and presence of full-length Pan1 (Figure 4.10C). The absence of End3 did not 
affect the localization of full-length Pan1. However, while the three essential regions 
could localize to the patch in the absence of End3, only Pan1AA205-855 could localize 
in the absence of both End3 and Pan1. Further characterization of Pan1 localization with 
other Pan1 fragments suggest that in the absence of End3 and Pan1, Pan1 needs at least 2 
EH domains and the LR2 in order to localize to the patch properly. Therefore, although 
End3 is not absolutely necessary for full-length Pan1 localization, it’s importance does 













 The Pan1-AID strain allowed for a more rigorous study of the necessity and 
sufficiency of all the various Pan1 domains and regions for Pan1 function. We found that 
the N-terminus of Pan1 only partially contributes to endocytosis and viability. For the 
functions we tested, the central domain is necessary and the C-terminus is neither 
necessary nor sufficient (summarized in Figure 4.5). Pan1’s EH domains and lipid 
binding domain have varying levels of importance based on the function tested and 
presence of other regions. End3, Pan1’s most stable binding partner, is necessary for 
viability in the absence of full-length Pan1.  
 We found that the most functionally important region of Pan1, AA702-1050, is 
the least-studied, leaving many questions open concerning the mechanisms for Pan1 
function. The known activities and interesting features of this region include: homo-
dimerization, End3 binding, Sla2 binding, a Prk1 consensus phosphorylation site, a lipid-
binding region, and a putative NLS domain, many of which show conservation among 
fungal species (Tang et al., 2000; Zeng et al., 2001; Miliaras and Wendland, 2004; 
Toshima et al., 2005; Kamińska et al., 2007; Toshima et al., 2007; Pierce et al., 2013). 
Additionally, there appears to be two more areas (AA855-892 and AA918-975) that are 
well conserved among fungal species, but have no assigned function. More careful study 
of Pan1’s central region is clearly warranted.  
 Although Pan1 has two well conserved EH domains, it was previously thought 
that Pan1’s EH1 could not compensate for EH2 loss (Wendland and Emr, 1998; 
Wendland et al., 1999; Maldonado-Baez et al., 2008; Suzuki et al., 2011). However, our 
work clearly shows that EH1 can function to support endocytosis and viability in the 
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absence of EH2 function (Figure 4.3, 4.4, and 4.7). Suzuki et al. showed that specific 
deletion of both Pan1 EH1 and EH2 does not abolish endocytosis, but our data using a 
fragment missing EH1, EH2, and the region between (LR2), does abolish the endocytic 
and essential function of Pan1, while just mutating these EH domains alone does not; this 
implicates a role for the LR2 region. Currently, the only known domains in LR2 are 10 
Prk1/Ark1 phosphorylation sites (Tang et al., 2000; Zeng et al., 2001; Toshima et al., 
2005; 2007). Are these sites critical for Pan1 function or are there unknown binding 
partners in the LR2? 
 The proper localization of proteins to patches is critical for their endocytic 
function, but the domains that are critical for this localization were unknown for Pan1. 
We found that the N-terminal and central regions of Pan1 independently localized to the 
patch; each had significantly decreased lifetimes in comparison to full-length Pan1, but 
had normal lifetime dynamics when combined (Figure 4.2). The C-terminus of Pan1 was 
neither necessary nor sufficient for localization. Both the N-terminal and central regions 
of Pan1 interact with proteins that arrive at the patch before or at the same time as Pan1, 
suggesting that these interactions contribute to Pan1 recruitment (Tang et al., 1997; 
Wendland and Emr, 1998; Wendland et al., 1999; Tang et al., 2000; Toshima et al., 
2007). Interestingly, some fragments, such as Pan1AA1-702 and 1-97, 402-855, could 
localize to the patch without supporting endocytosis. This demonstrated that regions 
important for endocytic localization and function could be separated. The exact 
mechanisms and critical domains of Pan1 localization are being further studied, but initial 
results indicate that two of the minimal fragments need at least one functioning EH 
domain for localization (Figure 4.7C).  
129
 Our work found two minimal regions of Pan1 that support viability and 
endocytosis: Pan1AA1-855 and AA402-1050 (Figure 4.3 and 4.4). They share the 
“common essential region” (AA402-855), which we showed is necessary for all Pan1 
functions, while the non-overlapping portions are very different. Do these two regions 
support endocytosis in similar, or in different ways? Pan1AA855-1050 interacts with 
Sla2 and the lipid membrane, both of which could help Pan1 properly localize to 
endocytic sites to perform its function (Toshima et al., 2007). The lipid binding site and 
the EH domain are not necessary for CME in Pan1 AA402-1050, suggesting that this 
fragment most likely can localize to the patch independently of these sites (Figure 4.7B 
and 4.8B). However, both sites in this minimal fragment are necessary for viability and 
are therefore necessary for Pan1’s essential function (Figure 4.7A and 4.8A). Does this 
essential function occur at the plasma membrane or a different membrane compartment in 
the cell? In contrast, Pan1AA1-402, which contains LR1, EH1, and part of LR2, could 
help localize Pan1 to the patch through Sla1 interactions or phosphoregulation. However, 
data in Figure 4.9 suggests that the phosphorylation motifs are not critical for growth or 
CME. That Pan1AA250-855 and Pan1AA1-97, 402-855 do not support endocytosis 
suggests an endocytic role for LR1, which binds Sla1 (Figure 4.3) (Tang et al., 2000; 
Zeng et al., 2001; Toshima et al., 2005; 2007). Thus, the contribution of Sla1 to the 
minimal Pan1 fragments needs to be tested. The exact binding domain of Sla1 also needs 
to be defined to determine if Pan1-Sla1 interaction is critical for endocytosis and/or 
viability. 
 Interestingly, we found two minimal regions of Pan1 that support viability and 
localize to patches, but do not fully restore endocytosis: Pan1AA250-855 and Pan1AA1-
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97, 402-855 (Figure 4.2-4.4). Each contains the common essential region, but the two 
non-overlapping regions contain different portions of the N-terminus. Each fragment 
needs one functioning NPF-binding motif in the EH domain to restore growth and 
localize to patches (Figure 4.7, A and C). Pan1AA250-402 contains EH1 and LR2, while 
the other has a glutamine rich N-terminus with an NPY motif. How are these regions 
contributing to Pan1’s essential function? Are there non-endocytic proteins that interact 
with Pan1 in these regions? Is Pan1’s essential function carried out at the endocytic 
patch?   
 We will continue to define the regions important for Pan1’s essential and 




































 In this dissertation, I have described the construction and use of a novel Pan1-
degron strain to uncover the mechanisms of Pan1’s function at the endocytic patch. Pan1-
AID was also used to further annotate the regions and domains of Pan1 that are critical 
for endocytic patch localization, endocytosis, and viability. The preceding chapters 
include data and in-depth discussion of these results. To conclude, I will discuss my 
results in the context of the endocytic field and hypothesize how our expanding 
knowledge of Pan1 can be applied to Intersectin and human disease.  
 Pan1 is a large, flexible scaffold protein that has a well-characterized role in CME 
and may have another, unknown, essential function in the cell. With Pan1-AID, Pan1 
protein was specifically and acutely depleted in live cells and we observed the resulting 
phenotypes. In the absence of Pan1, CME is arrested and cells begin to die. We currently 
do not know how or why the cells die in the absence of Pan1 and whether or not this is 
due to the CME arrest. CME is arrested because of a delay in maturation of the endocytic 
vesicle coat, an over activation of actin polymerization, and a disconnect between the 
actin machinery, coat proteins, and plasma membrane. Thus, we can conclude that Pan1 
is critical for strengthening these interactions during the vulnerable transition states of 
CME. The second EH domain and a portion of the central region of Pan1 are necessary, 
but not sufficient for all known Pan1 functions.  
 
The Pan1-AID strain as a tool for studying Pan1 function 
 Novel scientific discoveries depend on constant updates to existing techniques 
and new technologies. Big discoveries in the endocytosis field followed soon after 
revolutionary techniques were invented—electron microscopy, molecular genetics, 
133
fluorescent microscopy, and live cell imaging all played huge roles in elucidating the 
mysteries of the endocytic pathway. For the research of particular proteins within the 
process, the field relied heavily on gene deletion and mutation experiments in yeast. 
Much was learned from pan1 mutant alleles, but the PAN1 gene is essential and cannot 
be deleted. To expand the knowledge of Pan1’s function, it was necessary to use a novel 
method to specifically degrade Pan1 protein in live cells using conditions that did not 
cause any off-target effects on the cells. In this dissertation, the Auxin-Inducible Degron 
was used to acutely deplete Pan1 protein from cells, observe how endocytosis dynamics 
changed and which regions of Pan1 were important for these dynamics.  
 The degron allele method was originally developed over a decade ago, but recent 
upgrades to this technique have allowed for cleaner, more direct assays. The AID system 
depends on the interaction of plant proteins and hormones which should not, in theory, 
have any endogenous targets in yeast. While it appears that TIR1, the AID tag, and auxin 
are innocuous to yeast cells, it is critical that bioinformatics techniques are used in the 
future to evaluate if the presence of these plant proteins changes the expression levels or 
alters signaling pathway dynamics in yeast cells. The AID tag used in Chapter 2 is small 
enough that it should not affect Pan1 binding dynamics; however upgraded, smaller, AID 
tags have been developed that may be necessary to use for future Pan1 studies. One 
particular advantage of these smaller AID tags is they allow for an additional GFP tag to 
be added so the localization of the remaining Pan1 protein that has not yet been degraded 
can be observed. This Pan1-GFP-AID strain would confirm whether or not the few 
endocytic patches that do mature to the later stages contain a trace amount of Pan1 
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protein. The strain can continue to be used in the future to more clearly define each of 
Pan1’s roles and for a more careful characterization of Pan1’s protein architecture. 
 
Regulating transitions between stages of CME  
 One of the remaining open questions in the endocytic field is how each stage is 
coordinated in relation to the other stages. What proteins are important for the transitions, 
how are they recruited to the patch, and what signals are required for each stage? It was 
hypothesized that scaffolding proteins function to strengthen interactions between 
separate stages. However, studies of these scaffold proteins are inherently difficult due to 
their importance for growth and viability. Recent advances in methods have allowed for 
more precise observation of these scaffolding proteins. Boeke et al, 2014, identified the 
early coat protein Ede1 as the key coordinator for the initiation and early steps of 
endocytosis, but Ede1 was not critical for maintenance of the late coat. Sla2 and Ent1/2 
are critical for coupling the endocytic coat and actin machinery (Kaksonen et al., 2005; 
Skruzny et al., 2012). What coordinates the interactions between these two steps? Work 
in this dissertation provides evidence that Pan1 can coordinate the three transitions in 
CME: early coat to late coat, actin regulators to actin machinery, and coat/actin 
machinery to the plasma membrane (Chapter 3). As Pan1 interacts with Ede1, Ent1/2, 
and Sla2, it may function with these proteins to regulate a majority of the endocytic 
process (Figure 5.1) (Aguilar et al., 2003; Toshima et al., 2005, 2007; S. Barker and B. 
Wendland, unpublished observations). Another theory suggests that the type and amount 
of cargo present at the patch may provide a signal for maturation of the coat, but whether 











Initation Maturation Actin polymerization Scission
Figure 5.1: Key coordinators of CME transitions.
Top: Schematic of CME timeline. Bottom: Time periods during which Ede1, Pan1, 
and Sla2/Ent1/2 function to coordinate the transitions between CME stages. ?? = 
unknown regulator of transition.
??
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scission and uncoating, is not as clear; it is hypothesized that amphiphysin proteins are 
recruited to the vesicle neck by a combination of the membrane curvature and 
dephosphorylation of the membrane (Liu et al., 2006; 2009). Future work should focus 
on defining if this final stage is regulated by another scaffolding protein and/or the 
physiological properties of actin polymerization and membrane deformation.  
 
Functional characterization of Pan1 regions and domains  
 For the first time, the contribution of individual regions and domains of Pan1 to 
Pan1’s endocytic and essential functions could be determined using Pan1-AID. 
Previously, only fragments of Pan1 that supported viability could be studied. The work in 
Chapter 4 shows that there are three overlapping essential regions of Pan1; only one of 
these regions can fully support CME, suggesting that Pan1’s essential and endocytic 
functions can be separated (Figure 5.2).  
 This work supports previous research that found that Pan1’s C-terminal actin 
regulatory region is dispensable for endocytosis and viability (Duncan et al., 2001). 
Without the C-terminus, Pan1 resembles the short isoform of ITSN (Hussain et al., 
1999). If this actin regulatory region is not necessary for endocytosis or viability, why 
was it conserved? Is this region critical for another function of Pan1 through a yet 
undefined domain? Or is it there simply to ensure proper actin polymerization during 
CME?  
 We found that Pan1 AA402-855 is necessary, but not sufficient, for all Pan1 
functions. This region spans the second EH domain and a portion of the central region. 


























minimal common essential region
Conserved domain, unknown function
Figure 5.2: Three overlapping minimal essential regions of Pan1. 
Schematic of the three regions of Pan1 that are critical for CME and/or viability.
+ indicates this Pan1 fragment can restore CME or viability in Pan1-AID plus auxin;
- indicates this Pan1 fragment cannot restore CME or viability in Pan1-AID plus auxin. 
- -
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making biochemical experiments technically difficult. Currently, only three proteins are 
known to bind in this region—End3, Sla2, and Pan1 itself. Are these protein interactions 
critical for Pan1’s endocytic and essential roles? This region also contains some putative 
NLS and phosphorylation domains whose contributions are yet to be studied. There are 
also two well-conserved regions that may contribute to Pan1’s unknown essential 
function.  
 To learn more about the elusive central region and essential functions of Pan1, 
two screens should be done to identify the involved pathways and what protein 
interactions are important. A screen for novel binding partners of Pan1 AA402-855 may 
provide evidence of previously unknown endocytic proteins and/or essential pathway 
partners. A high-copy suppressor screen for proteins that can support viability in the 
presence of Pan1’s minimal essential region may also show Pan1’s essential function.   
 
What is the essential function of Pan1? 
 Pan1 has historically been characterized as a CME scaffold protein, but CME is 
not an essential process (Chu et al., 1996; Madania et al., 1999; Kaksonen et al., 2005; 
Newpher and Lemmon, 2006; Prosser et al., 2011). Intersectin, Pan1’s mammalian 
homologue, has signaling roles independent of its CME role; does Pan1 also have 
signaling roles and could this be its essential function? Or is Pan1 only involved in 
endocytosis? One way to deduce how a protein keeps cells alive is to observe how cells 
die in the absence of the protein. Chapter 2 shows that in the absence of Pan1, cells die 
quickly and conventional death inhibitor drugs cannot inhibit the death pathway(s). More 
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work into how and why these cells are dying is necessary to determine why Pan1 is 
essential. 
 Yeast have only two defined endocytic pathways: CME and Rho1-dependent 
clathrin-independent endocytosis (CIE). The presence of a CIE pathway in yeast is a 
relatively new discovery and not much is known about the proteins involved (Prosser et 
al., 2011). So far, Pan1 has only been shown to function in CME, but its role in CIE has 
not yet been tested. Intersectin has been show to act in at least one CIE pathway 
(caveolin-dependent endocytosis); thus, it can by hypothesized that Pan1 may be 
involved in CIE as well (Predescu et al., 2003; Klein et al., 2009). If Pan1 were necessary 
for both pathways, then endocytosis would be completely abolished in the absence of 
Pan1 if these are the only two endocytic routes. A complete block of endocytic routes 
would be extremely detrimental to cells, as they could not uptake necessary nutrients, 
respond to stress signals, or regulate membrane composition. Does death due to a full 
block of endocytosis resemble death due to the absence of Pan1? Future work will be 
done to see if Pan1 functions in the yeast CIE pathway and if the block in endocytosis is 
what leads to cell death.  
 Pan1 could be acting similarly to Intersectin and act as a both a scaffold for 
signaling and endocytosis pathways. Pan1 has historically been considered only a CME 
protein, so very little research has been done to see if Pan1 has other roles in the cell. 
Two studies found putative domains of Pan1 that do not seem to be related to CME: a 
nuclear localization signal (NLS) and a stress-induced phosphorylation site (Kaminska et 
al., 2007; Reiter et al., 2012). Only one other endocytic protein in yeast, Sla1, has been 
shown to localize to the nucleus, but the function of this localization is not known 
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(Gardiner et al., 2007). Could Pan1 and Sla1, which form a protein complex, be traveling 
to and functioning in the nucleus together? Using GFP localization, future work will need 
to confirm if, when, and how these proteins localize to the nucleus. Recent work found a 
novel Hog1-dependent phosphorylation site of Pan1 that is highly phosphorylated in 
response to osmotic stress (Reiter et al., 2012). Is this phosphorylation site important for 
Pan1’s essential function? A cell’s stress response system is intimately linked to 
endocytosis; cells will often uptake stress receptors and change the membrane 
composition via endocytosis when a harmful environmental factor sensed. Using Pan1-
AID, the contribution of this Hog1 phosphorylation site to localization, endocytosis, and 
viability can be tested. The phosphorylation site is not within Pan1’s essential region, so 
while Pan1 may have a role in this stress particular response, it is probably not Pan1’s 
essential function. However, this does not rule out the possibility that Pan1 could be 
involved in other stress responses that could be essential. 
 
The future of endocytosis studies 
 This dissertation focuses on Pan1’s scaffolding role in endocytosis and which 
regions of Pan1 contribute to CME and viability. These experiments can be done with 
relative efficiency in yeast compared to studies of Intersectin in mammalian systems. 
Thus our novel findings of Pan1 can be used to design more specific experiments of 
ITSN function. The AID system can be used in mammalian systems and thus experiments 
with AID tagged ITSN1/2 in mammalian cells can confirm that Pan1 and ITSN have 
similar scaffolding roles. We hypothesize that without ITSN, CME would have a similar 
phenotype as in yeast cells without Pan1—delayed maturation of the endocytic coat, the 
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appearance of actin flares, and a disconnect between the coat, actin, and membrane. The 
ITSN-AID cell lines could also be used to see if there are similarities between which 
fragments of ITSN and Pan1 are critical for various functions. There is some knowledge 
about which regions of ITSN are important for its alternative signaling roles; if one of 
these regions turns out to be essential, then this knowledge can be applied to future Pan1 
research on the mechanisms of its potential signaling roles.  
 The more that is known about the similarities and differences between ITSN and 
Pan1, the better we can use Pan1 and yeast as a model system for basic cellular functions 
in wild type and disease states. The most recent yeast model of Alzheimer’s Disease 
shows deficiencies in CME (Treusch et al., 2012). More work needs to be done to 
characterize how and why CME is misregulated and which proteins are involved. By 
combining Pan1-AID and the yeast AD model, the role of Pan1 in the AD can be 
assessed and genetic and drug screens can be performed to discover novel therapeutic 
targets. The development of more yeast models of human disease will complement work 
done in mammalian systems and lead to a better understanding of diseases and the 
discovery of therapeutic targets. Additionally, further characterization of endocytic 
trafficking is essential to develop therapeutics that can be targeted to specific intracellular 


































The Pan1-DHFR allele was created by Karen Whitworth; all results presented in this 




 Although much research has been done to characterize the various binding 
regions and functions of Pan1 important in endocytosis, the exact mechanisms of Pan1 
function have yet to be discovered due to Pan1’s essential nature. Temperature-sensitive 
(ts) alleles and conditional expression of Pan1 were unsuccessful at completely removing 
all of Pan1 function; therefore it was critical to create a degron allele of Pan1 in which 
Pan1 protein could be conditionally and specifically depleted. Prior to creation of the 
Pan1-AID degron strain, another Pan1-degron allele was used to specifically degrade 
Pan1 protein in nonpermissive conditions. This strain, pan1-td, used the temperature-
sensitive DHFR-degron tag combined with galactose-induced overexpression of the E3 
ubiquitin ligase Ubr1 to degrade Pan1 in the non-permissive conditions: 37ºC and 
galactose media (Sanchez-Diaz et al., 2004). Using this strain, it was confirmed that Pan1 
is required for cell growth and endocytosis. A candidate high-copy suppressor screen 
using pan1-td found that Cell Wall Integrity pathway proteins could restore growth to 
pan1-td cells; but this was specific to the pan1-td strain and most-likely a false positive 
as these proteins did not rescue growth of Pan1-AID. Therefore, due to the slow 
degradation of Pan1 and the off-target effects of the non-permissive conditions in pan1-td 








In order to elucidate a protein’s function, a common method in genetics is to 
simply delete the encoding gene from the organism’s genome and observe the resulting 
phenotypes. However, essential genes cannot be deleted and instead must be mutated or 
conditionally inactivated. Although several temperature sensitive alleles of PAN1 exist, 
these most likely do not eliminate all of Pan1’s functions. Typically, to induce 
conditional deletion, a gene can be put under the control of the regulatable galactose 
promoter. However, Pan1 contains many methionines and internal start sites that allow 
truncated versions of Pan1 lacking any 5’ UTR sequences to be expressed constitutively 
(Tang and Cai, 1996, K. Whitworth and B. Wendland, unpublished observations).  There 
is also a phenotypic lag in galactose regulation experiments (and inactivation of ts 
mutants at nonpermissive temperatures) because it could take several hours for the 
existing protein to be degraded in the cell once the galactose promoter has been 
repressed. A more efficient and specific way to conditionally knock-out a gene in yeast is 
to promote protein degradation through the genomic fusion of the gene with a degron-
fusion allele.  
Our lab has used the methods of Sanchez-Diaz et al. (2004) to produce a degron-
fusion allele of PAN1 (pan1-td). In pan1-td, PAN1 is fused with a mouse mutant allele of 
dihydrofolate reductase (DHFR) in which there is a P66L mutation and an N-terminal 
ubiquitin peptide. The ubiquitin is cleaved co-translationally from the N-terminus of 
DHFR exposing an internal residue that has been mutated from valine to arginine. These 
mutations cause a conformational change at the nonpermissive temperature (37°C) that 
exposes the N-terminal arginine on the surface. Due to the N-end rule, which relates the 
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stability of a protein to its N-terminal residue, the protein with the unstable N-terminal 
arginine is targeted for ubiquitination by the E3 ubiquitin ligase, Ubr1, resulting in the 
rapid degradation of DHFR and the protein to which it is fused. These conditions also 
provide internal controls for the strain because high-temperature or galactose induction 
alone are not responsible for the phenotypes observed. Using pan1-td, we found that cells 
are inviable and endocytosis is arrested under the nonpermissive conditions due to the 
loss of Pan1 protein.  
One of the advantages of the pan1-td system is the ability to perform genetic 
screens to discover proteins that can bypass the loss of Pan1 to restore growth in the 
nonpermissive conditions. A candidate screen found that several components of the Cell 
Wall Integrity (CWI) pathway were able to restore growth of pan1-td cells in non-
permissive conditions when overexpressed. In cells, the CWI pathway is used to sense 
extracellular environments and stressors; specific stressors, such as temperature and pH, 
can activate the pathway and signal for the cell to upregulate expression of proteins that 
protect the cell from harmful environments. It was originally thought that Pan1 might be 
involved in the stress signaling; however, high-copy expression of the CWI components 
was not able to restore growth in another Pan1 degron system, Pan1-AID. It was 
concluded that the CWI pathway components were restoring growth by over activating 
the CWI pathway, which protected the cells in the harmful non-permissive conditions of 
pan1-td. Therefore, all future genetic screens will be conducted in strains, such as Pan1-




MATERIALS AND METHODS 
Media and Growth Conditions 
Permissive conditions: yeast cells were grown in rich (yeast extract-peptone) or synthetic 
(yeast nitrogenous base with amino acids selection of plasmid maintenance) medium with 
2% dextrose or raffinose at 30°C.  
Pan1-td Non-permissive conditions: yeast cells were grown in rich or synthetic medium 
with 2% galactose at 37°C. For pACT-GEV experiments, Β-estradiol was added at a final 
concentration of 1µM.  
Pan1-AID non-permissive conditions: 1mM NAA was added to synthetic media plates.  
 
Strains and Plasmids 
The yeast strains and plasmids used in this study are listed in Tables AI.1 & AI.2, 
respectively. Strains were constructed using PCR-based genomic integration as described 
previously (Longtine et al., 1998; Goldstein and McCusker, 1999; Nishimura et al., 
2009). DNA manipulations for plasmid construction were preformed using standard 
techniques, employing either T4 DNA polymerase-mediated ligations in Escherichia coli 
or homologous recombination with overlapping DNA fragments followed by plasmid 
rescue in S. cerevisiae. All restrictions enzymes were purchased from New England 
Biolabs (Ispwich, MA). 
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TABLE AI.I Yeast strains used in this chapter 
Strain Genotype Source 
W303 MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100  Laboratory Strain 
BWY3781 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
HIS::pGAL-UBR1 Laboratory Strain 
BWY4150 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
HIS::pGAL-UBR1 URA::ub-DHFRts-HA-Pan1 Laboratory Strain 
BWY5270 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
LEU2::pACT-GEV This Study 
BWY5271 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
HIS::pGAL-UBR1 LEU2::pACT-GEV This Study 
BWY5273 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
HIS::pGAL-UBR1 URA::ub-DHFRts-HA-Pan1 
LEU2::pACT-GEV This Study 
BWY5274 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
HIS::pGAL-UBR1 URA::ub-Leu-DHFRts-HA-Pan1 This Study 
BWY5275 
MATa ura3-1 his3-11 leu2,3112 trp1-1 can1-100 
HIS::pGAL-UBR1 URA::ub-Ile-DHFRts-HA-Pan1 This Study 
BWY5394 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 
can1-100 ADH1-OsTIR1-9myc::URA3 ade2::ADE2 
HisΔ::URA Pan1-AID::G418 This Study 
 
TABLE AI.2 Plasmids used in this chapter 
Plasmid Details Description Source 
pRS426 2µ, URA3  Empty Vector (EV) 
Laboratory 
plasmid 
pBW1473 pRS426::MID2 (2µ, URA3) pMid2.426 
(Prosser et 
al., 2011) 








pBW1953 pRS426::RHO2 (2µ, URA3) pRho2.426 
Laboratory 
plasmid 
pBW2053 Yep24::ROM1 (2µ, URA3) pRom1.426 
(Prosser et 
al., 2011) 
pBW2054 Yep24::RHO1 (2µ, URA3) pRHO1.426 
(Prosser et 
al., 2011) 
pBW2240 pACT1-GEV (leu2) pACT-GEV 
Goschling 
Lab 
pBW2299 pCup-Ub-DHFRts-HA, H2L (ura3) DHFR-Leu This study 





TCA Precipitation:  
Mid to late-log phase cells in permissive or non-permissive conditions at indicated time 
points were harvested and resuspended in 1ml of 10% trichloroacetic acid (TCA) with 
1mM 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF, a protease inhibitor), incubated 
on ice for 20 min, and precipitates were centrifuged at 14,000 rpm for 10 min at 4°C. 
Precipitates were washed twice with cold acetone, resuspended by sonication, and air-
dried. Protein samples were processed for SDS-PAGE separation by adding 2x protein 
sample buffer with 1mM AEBSF and solubilized by bead disruption.  
 
SDS-PAGE and Immunoblotting: 
Proteins were separated on polyacrylamide mini gels (7.5%) at 27mA in SDS running 
buffer (3mM SDS, 25mM Tris base, 192mm glycine) and then transferred onto 
nitrocellulose membranes at 80V for 90 min in cold transfer buffer (20% methanol, 
0.0375% SDS, 48mM Tris base, 30mM glycine). The membranes were blocked in 5% 
milk in TBST (10mM Tris, pH 7.5, 0.25M NaCl, 0.025% Tween-20). Blots were 
incubated in the specified primary antibody overnight at the following concentrations: 
Rabbit-anti-Pan1 was a gift from D.G. Drubin and was used at 1:10,000; Rabbit-anti-
Act1 was a gift from D. Pruyne and was used at 1:5,000. The blots were washed 3 times 
in TBST, incubated with secondary antibodies conjugated to HRP (Pierce, Rockford, IL) 
diluted 1:2,000 in milk solution for 45 min. Blots were washed again 3 times in TBST, 
and then developed with chemiluminescent substrate (Solution 1:2.5mM Luminol, 
400uM paracoumaric acid, 100mM Tris-HCl, pH 8.5. Solution 2: 5.4mM H2O2, 100mM 
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Tris-HCl, pH 8.5) for 2 min at room temperature. Chemiluminescence images were 
acquired using a FluorChem M FM0455 imager.  
 
Growth Assays 
Serial Dilutions: Log phase cells were grown in permissive conditions and diluted to 
OD600 of 0.25, from which four 1:5 serial dilutions were plated in permissive and non-
permissive conditions and grown for three days at 30°C.  
 
FM4-64 staining 
FM4-64 images were collected using a Zeiss Axiovert 135TV inverted microscope (Carl 
Zeiss MicroImaging, Inc., Thornwood, NY) with a Sensicam QE CCD camera (Cooke, 
Romulus, MI), Zeiss 100x 1.4 NA Plan-Apochromat objective, motorized filter wheels, 
fluorescein isothiocynate (FITC) and Texas Red filter sets (Semrock, Rochester, NY), 
and Slidebook 5.0 software (Intelligent Imaging Innovations, Denver, CO). Images were 
captured with 500ms exposure, identical binning, intensification and illumination 
intensity. Log phase cells were grown in permissive conditions and were switched to 
permissive or non-permissive conditions for 60 m. For FM4-64 labeling, cell aliquots 
were transferred to an eppendorf tube with 10ug/ml FM4-64 (Molecular Probes, Eugene, 
OR) and incubated for 15 min at 30°C or 37°C. The cells were washed twice with fresh 
media to remove excess FM4-64, resuspended in 100ul fresh media, and then put on ice 
until visualization at the microscope. Cells were spotted onto uncoated glass slides and 




In pan1-td cells, Pan1 protein is depleted and cell growth is inhibited upon the 
switch to nonpermissive conditions 
In the pan1-td strain, PAN1 is N-terminally tagged with the temperature sensitive 
DHFR mutant and the expression of the E3 ubiquitin ligase, Ubr1, is placed under 
galactose regulation (Sanchez-Diaz et al., 2004). In the non-permissive conditions, 37°C 
and galactose as the carbon source, Ubr1 is overexpressed and recognizes the N-terminal 
arginine of the DHFR tag (Figure AI.1A). Neither over activation of Ubr1, nor 
temperature shifts alone affect the levels of Pan1 or cell growth (Figure AI.1, B and C). 
However, when both nonpermissive conditions are combined in pan1-td cells, Pan1 
protein is depleted within 4 hours and the cells cannot grow. Therefore, pan1-td can be 
used to assess the acute phenotypes of the loss of Pan1 on cellular processes, which will 
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Figure AI.1. Pan1-td protein is depleted and cells do not grow in nonpermissive 
conditions. 
(A) Schematic of the DHFR degron tag attached to Pan1 in the permissive and non-
permissive conditions. (B) Immunoblot detecting Pan1 of pan1-td cell lysates grown for 
the indicated times in the permissive or non-permissive conditions. (C) Serial dilutions 




Endocytosis is arrested in the absence of Pan1 
 
 Pan1 is presumed to play a critical role as an endocytic scaffolding protein; thus, 
we hypothesized that upon removal of Pan1, endocytosis would be negatively affected. 
The lipophilic dye FM4-64 binds to the plasma membrane and becomes fluorescent and 
marks membranes as they are internalized through endocytosis and targeted to the 
vacuole. In pan1-td cells in the permissive conditions, FM4-64 is internalized normally, 
but upon the switch to nonpermissive conditions, FM4-64 is trapped at the plasma 
membrane (Figure AI.2). This endocytic arrest confirms that Pan1 is essential for 



















Figure AI.2. Endocytosis is arrested in pan1-td cells in the nonpermissive condi-
tions.
Representative images of log-phase cultures grown at 37ºC in permissive or non-
permissive conditions for 60 min before labeling with FM4-64 for 15 min.
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Optimization of Ubr1 recognition of DHFR did not increase Pan1 degradation in 
pan1-td 
 Degradation of Pan1 in pan1-td is dependent upon the temperature sensitive 
conformational change of DHFR, which exposes an N-terminal arginine that is 
recognized by Ubr1 for degradation. In pan1-td, the recognition and subsequent 
degradation of Pan1 takes about 3-4 hours, which is significantly slower than the 
published DHFR model, which degrades the target protein in less than 30 mins (Sanchez-
Diaz et al., 2004). Recent work studied the importance of the second amino acid after the 
first arginine for N-end rule degradation and found that hydrophobic residues are ideal at 
the second position for efficient degradation (Choi et al. 2010). Additionally, they found 
that proline and histidine were the least efficient; DHFR’s second amino acid is histidine. 
To increase efficiency of pan1-td degradation, the second amino acid of DHFR was 
mutated from histidine to either leucine (pan1-td-leu) or isoleucine (pan1-td-ile). Both 
pan1-td-leu and pan1-td-ile displayed similar growth phenotypes to pan1-td in the 
permissive and nonpermissive conditions (Figure AI.3A). However, Pan1 was degraded 
in a similar time frame to pan1-td in pan1-td-leu and pan1-td-ile strains (Figure AI.3, B 
and C). Thus, optimization of the second amino acid did not increase N-end rule 
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Figure AI.3. Optimization of DHFR tag does not increase efficiency of pan1-td 
degradation.
(A) Serial dilutions of indicated strains grown 3 d in labeled conditions. (B and C) Immu-
noblots detecting Pan1 and Actin of pan1-td-ile (B) and pan1-td-leu (C) cell lysates 
grown for the indicated times in the permissive or non-permissive conditions. Actin is 






B-estradiol induction of Ubr1 increases Pan1 degradation efficiency in pan1-td 
 The non-permissive conditions of pan1-td are high-temperature (37ºC) to induce 
the DHFR conformational change and galactose as the carbon source to induce 
overexpression of Ubr1. Thus, pan1-td cells must be grown at 30ºC with raffinose or 
dextrose as the carbon source. The abrupt carbon source switch necessary for Ubr1 
expression may induce stress responses in the cells that can have off-target effects. To 
avoid the carbon source switch, a chimeric transcriptional activator, Gal4dbd.ER.V16 
(GEV) can be used to recognize and activate transcription at Gal4 consensus sites upon 
addition of the hormone B-estradiol, instead of galactose, to the media. The pACT-GEV 
activator was constitutively expressed under the actin promoter in pan1-td cells and thus 
the new nonpermissive conditions are the addition of B-estradiol and the temperature 
shift. In the nonpermissive conditions, pan1-td pACT-GEV degraded Pan1 faster than 
pan1-td and resulted in a growth inhibition (Figure AI.4). Unfortunately, B-estradiol 
alone induced a growth defect in both pan1-td and WT cells containing pACT-GEV 
(Figure AI.4B). This suggests that pACT-GEV and/or B-estradiol may have other, 
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Figure AI.4. Using pACT-GEV and B-estradiol to induce Gal-expression of Ubr1 
does not increase efficiency of pan1-td degradation. 
(A and B) Immunoblots detecting Pan1 and Actin of pan1-td, pACT-GEV cell lysates 
grown for the indicated times in the permissive or non-permissive conditions. Actin is 





Cell Wall Integrity pathway components restore growth of pan1-td, but not Pan1-
AID cells 
A preliminary candidate high-copy suppressor screen found that pan1-td’s 
lethality under nonpermissive conditions is suppressed by overexpression of Rom2, 
Rho2, and Pkc1 (K. Whitworth and B. Wendland, unpublished).  All three are part of the 
complex CWI/nutrient-sensing pathway, which is activated during environmental stress 
to strengthen and repair the cell wall (Fuchs and Mylonakis, 2009). Stress sensors 
converge to activate Rom2, which is the guanine nucleotide exchange factor (GEF) of the 
GTPases Rho1 and Rho2 (Bickle et al., 1998). Upon activation, Rho1/2 can activate 
several pathways to regulate actin cytoskeleton organization, cell wall biosynthesis, and 
transcription of other CWI genes (Levin, 2005). One of these pathways activates another 
high-copy suppressor of pan1-td: Pkc1, which triggers a MAP-kinase cascade that 
ultimately leads to transcription of genes involved in CWI  (Figure AI.5) (Heinisch 
1999). Activation of Rom2 is downstream of several environmental stress sensors. Of the 
two classic cell wall pH and heat sensors, Mid2 and Wsc1, only Mid2 can rescue pan1-td 
cells (Figure AI.5) (Levin, 2005). The nonpermissive conditions of pan1-td alone may 
induce stress pathways; thus, overexpression of these CWI pathway components could be 
rescuing pan1-td cells simply by priming the stress pathways prior to induction of cell 
wall stress versus inducing a Pan1-dependent essential pathway. To test this, the Pan1-
AID system was used to test if high-copy expression of CWI pathway components could 
restore growth in the absence of Pan1 and stress induction. None of these proteins were 
able to restore growth of Pan1-AID cells in the presence of auxin (Figure AI.5). This 













Figure AI.5. Overexpression of Cell Wall Integrity proteins rescues growth of 
pan1-td, but not Pan1-AID, in non-permissive conditions. 
Serial dilutions of pan1-td and Pan1-AID cells containing indicated high-copy plasmids 
(on left) grown for 3 d in respective non-permissive conditions. 
Plasmids:
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 Creating an efficient and robust system to deplete cells of a target protein in 
nonpermissive conditions without creating extra stress on the cell is critical for 
uncovering the function of essential proteins. The DHFR-galactose degron system, 
introduced in Sanchez-Diaz et al. (2004), does deplete the target protein upon the switch 
to nonpermissive conditions. However, these nonpermissive conditions are not innocuous 
and result in their own phenotypes, which can occlude phenotypes due to loss of the 
target protein. It is imperative to consider these caveats when evaluating results and 
include proper controls to validate all phenotypes found using the DHFR-degron system. 
This system was used to create the pan1-td strain, which targets Pan1 for degradation. 
Upon the switch to the nonpermissive conditions, Pan1 protein is degraded, cells cannot 
grow, and endocytosis is arrested (Figure AI.1 and AI.2). These results corroborate those 
from Pan1-AID to confirm that Pan1 is essential for growth and endocytosis (Chapter 2).  
 In the pan1-td cells, Pan1 protein is depleted between 3-4 hours after the switch to 
nonpermissive conditions; this is depletion is significantly slower than previously 
reported results for other proteins using the DHFR-degron system, which show complete 
degradation of target protein within 30 minutes (Sanchez-Diaz et al., 2004). Attempts to 
increase the efficiency of degradation by optimizing recognition of the DHFR-tag by 
Ubr1 were not successful (Figure AI.3). This suggests that the slow rate of Pan1 
degradation may be specific to Pan1 and not the DHFR system.  
 Yeast cells require a source of carbon in the media in order to thrive. Although 
there are several sugars that can be used for this carbon source, not all are optimal for 
robust growth and switching the carbon source can often activate cellular stress 
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pathways. In pan1-td experiments, cells must be grown in raffinose media, and then 
switched to media containing galactose to promote Ubr1 overexpression. Cells do not 
grow well in either condition and the carbon source switch activates stress pathways. To 
avoid this carbon source shift, the pACT-GEV system was utilized which uses the 
hormone B-estradiol to induce the galactose promoter through pACT-GEV. Using this 
system in pan1-td cells did result in faster degradation of Pan1 protein, but the presence 
of B-estradiol did slow growth at the permissive temperature, 30ºC (Figure AI.4). 
Therefore, although the B-estradiol system does remove the stress of the carbon source 
shift, it adds a new stress to the cells and is therefore not an ideal system for the study of 
Pan1 function.  
 A candidate screen that was conducted to uncover the essential function of Pan1 
found that several components of the Cell Wall Integrity (CWI) pathway could restore 
growth of pan1-td cells in non-permissive conditions. The CWI pathway is activated 
upon cellular stress and upregulates pathways used to protect the cell from these harmful 
environments. However, these CWI proteins, Rom2, Rho2, Pkc1, and Mid2, when 
overexpressed were not able to restore growth of Pan1-AID cells in the presence of auxin 
(Figure AI.5). This means that CWI pathway rescue is specific to pan1-td cells and the 
DHFR degron system, not depletion of Pan1. Overexpression of these components may 
be priming pan1-td cells for the switch to the stressful, non-permissive conditions, 
allowing for cell growth. Therefore, Pan1 may not be involved in the CWI pathway for 
its essential function. 
 For future study of Pan1 functions, it is imperative to use a degron system that 
introduces the least amount of additional stress to the cells. The Pan1-AID system, as 
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opposed to the pan1-td system, only has one variable, addition of auxin, to induce 
degradation of Pan1 protein (Pan1-AID system explained in Chapter 2). Auxin and TIR1, 
as opposed to temperature and carbon source shifts and Ubr1, have no obvious off-target 
effects on cells. Therefore, Pan1-AID will be used for all further study of Pan1’s 




APPENDIX 2: UNCOVERING THE ESSENTIAL 
































 Pan1 regulates and interacts with several endocytic proteins; however, the current 
list may not be complete. By analogy to Pan1’s mammalian homologue ITSN, Pan1 may 
function in other pathways; thus, learning more about these novel Pan1 interactions 
should provide insight into ITSN functions. The Pan1-AID strain provides an efficient 
way to screen for pathways that can suppress lethality in nonpermissive conditions. A 
high-copy expression library was transformed into the Pan1-AID strain and colonies were 
tested for rescue of growth of Pan1-AID in the nonpermissive conditions. A trial screen 
was completed and one candidate gene, Das1, was validated. Das1 is an F-box protein 
and might be expected to compete with TIR1 for binding to the SCF complex; however, 
it appears that in the presence of high-copy Das1, Pan1-AID was still degraded. Das1 
restored growth of Pan1-AID cells, but it did not restore endocytosis nor did it restore 
growth of other AID-tagged strains or a pan1Δ strain. Further experimentation is required 












 There are currently over 60 proteins associated with the clathrin-mediated 
endocytic pathway and Pan1 is known to associate, either directly or indirectly, with a 
number of these. There are still a number of open questions regarding the endocytic 
process, so it is important to continue to search for novel proteins and interactions 
involved in the process. Pan1 is thought to have an additional, essential and non-
endocytic role in the cells. CME is not an essential process in yeast and Pan1’s 
mammalian homologue, Intersectin (ITSN), has non-endocytic functions, thus we 
hypothesized that Pan1 may have another, non-endocytic, essential role (Payne et al., 
1988; Chu et al., 1996; Madania et al., 1999; Kaksonen et al., 2005; Newpher and 
Lemmon, 2006; Prosser et al., 2011, Tysba et al., 2011).  
 Genetic screens in yeast are an efficient and rapid method to uncover novel 
proteins involved in conserved cellular processes. In a high-copy suppressor screen, a 
genetic library of plasmids containing fragments of genomic DNA is transformed into a 
strain lacking a particular protein or pathway. Candidate high-copy suppressor proteins 
are selected by their ability to restore the targeted defect phenotype. The Pan1-AID strain 
provides a unique opportunity to discover, for the first time, proteins that can bypass the 
loss of Pan1 by restoring growth in the presence of auxin. Candidate high-copy 
suppressors could either upregulate an essential pathway that Pan1 is involved in or a 
parallel pathway that functions similarly. Alternatively, a high-copy suppressor could 
inhibit the death pathway that is induced in the absence of Pan1. Discovery of a protein in 
either of these groups would provide insight into Pan1’s unknown essential function(s).  
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 From the Pan1-AID high-copy suppressor screen, one high-copy suppressor was 
validated—Das1 (YJL149w). Although Das1 is an F-box protein, it did not appear to 
compete for binding with TIR1 to the SCF complex, as Pan1 protein was still depleted in 
the presence of high-copy Das1. Das1 was not able to restore the growth in a pan1Δ 
strain, indicating that Das1 may not be upregulating an essential pathway. The exact 



















MATERIALS AND METHODS 
Media and Growth Conditions 
Yeast cells were grown in rich (yeast extract-peptone) or synthetic (yeast nitrogenous 
base with amino acids selection of plasmid maintenance) medium with 2% dextrose. For 
experiments using auxin in liquid cultures, 3-Indoleacetic acid (Sigma I2886) was added 
to synthetic media to a final concentration of 500µm. For experiments using auxin on 
solid media, 1-Naphthaleneacetic acid (Sigma N0640) was added to synthetic media to a 
final concentration of 1mM. For plasmid shuffles, 	   
 
Strains and Plasmids 
The yeast strains and plasmids used in this study are listed in Tables AII.1 and AII.2, 
respectively. Strains were constructed using PCR-based genomic integration as described 
previously (Longtine et al., 1998; Goldstein and McCusker, 1999; Nishimura et al., 
2009). DNA manipulations for plasmid construction were preformed using standard 
techniques, employing either T4 DNA polymerase-mediated ligations in Escherichia coli 
or homologous recombination with overlapping DNA fragments followed by plasmid 
rescue in S. cerevisiae. All restrictions enzymes were purchased from New England 
Biolabs (Ispwich, MA).  
 
TABLE AII.1 Yeast strains used in this chapter 
Strain Genotype Source 
BWY2618 
MATα ura3-1 ade2-1 his3-11 leu2,3112 trp1-1 can1-
100 pan1::HIS Pan1.416 (pBW513) Laboratory Strain 
BWY5393 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 
can1-100 ade2::ADE2 ADH1-OsTIR1-9myc::URA3 
HisΔ::URA This Study 
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BWY5394 
MATα ura3-1 ade2-1 his3-11, 15 leu2-3,112 trp1-1 
can1-100 ADH1-OsTIR1-9myc::URA3 ade2::ADE2 
HisΔ::URA Pan1-AID::G418 This Study 
BWY6481 
MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 lys2Δ0 QRI1-
TAP-AID::URA3 Cunningham Lab 
BWY6482 
MATa his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 lys2Δ0 Las17-
TAP-AID-Flag::URA3 Cunningham Lab 
 
 
TABLE AII.2 Plasmids used in this chapter 
Plasmid Details Description Source 
pRS425 2µ, LEU2 Empty Vector (EV) 
Laboratory 
plasmid 
pRS426 2µ, URA3 Empty Vector (EV)  
pBW010 pRS415::PAN1 (CEN, LEU2) pPan1.415 Emr Lab 
pBW513 pRS416::PAN1 (CEN, URA3) pPan1.416 
Sachs et al., 
1992 
pBW2652 pRS426::DAS1 (2µ, URA3) pDas1.426 This study 
pBW2695 pRS425::DAS1 (2µ, LEU2) pDas1.425 This study 
 
High-copy suppressor screen 
A uracil high-copy library expressing genomic fragments was transferred into Pan1-AID 
cells and plated onto YNB-uracil-auxin plates. Colonies were replicated plated onto 
YNB-uracil + 1mM NAA plates to select for colonies that restored growth in the 
presence of auxin. Positive colonies were screened for false positives by selecting for 
revertants (colonies that restore growth in the presence of auxin after plasmid curing on 
5FOA) and did not contain Pan1 on the plasmid. Plasmids were rescued from candidate 
colonies and sequenced.  
 
Protein Expression 
TCA Precipitation:  
Mid to late-log phase cells -/+ Auxin at indicated time points were harvested and 
resuspended in 1ml of 10% trichloroacetic acid (TCA) with 1mM 4-(2-
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aminoethyl)benzenesulfonyl fluoride (AEBSF, a protease inhibitor), incubated on ice for 
20 min, and precipitates were centrifuged at 14,000 rpm for 10 min at 4°C. Precipitates 
were washed twice with cold acetone, resuspended by sonication, and air-dried. Protein 
samples were processed for SDS-PAGE separation by adding 2x protein sample buffer 
with 1mM AEBSF and solubilized by bead disruption.  
 
SDS-PAGE and Immunoblotting: 
Proteins were separated on polyacrylamide mini gels (7.5%) at 27mA in SDS running 
buffer (3mM SDS, 25mM Tris base, 192mm glycine) and then transferred onto 
nitrocellulose membranes at 80V for 90 min in cold transfer buffer (20% methanol, 
0.0375% SDS, 48mM Tris base, 30mM glycine). The membranes were blocked in 5% 
milk in TBST (10mM Tris, pH 7.5, 0.25M NaCl, 0.025% Tween-20). Blots were 
incubated in the specified primary antibody overnight at the following concentrations: 
Rabbit-anti-Pan1 was a gift from D.G. Drubin and was used at 1:10,000; Rabbit-anti-
Act1 was a gift from D. Pruyne and was used at 1:5,000. The blots were washed 3 times 
in TBST, incubated with secondary antibodies conjugated to HRP (Pierce, Rockford, IL) 
diluted 1:2,000 in milk solution for 45 min. Blots were washed again 3 times in TBST, 
and then developed with chemiluminescent substrate (Solution 1:2.5mM Luminol, 
400uM paracoumaric acid, 100mM Tris-HCl, pH 8.5. Solution 2: 5.4mM H2O2, 100mM 
Tris-HCl, pH 8.5) for 2 min at room temperature. Chemiluminescence images were 





Serial Dilutions: Log phase cells were diluted to OD600 of 0.25, from which four 1:5 
serial dilutions were plated on YNB-tryptophan minus or plus 1mm NAA and grown for 
three days at 30°C.  
Plasmid Shuffle: pan1Δ cells expressing PAN1 from a URA3 plasmid were used for 
counterselection on 5-FOA plates. Cells cotransformed with PAN1 or DAS1 LEU2 




Mup1-pHlourin images were collected using a Zeiss Axiovert 135TV inverted 
microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY) with a Sensicam QE CCD 
camera (Cooke, Romulus, MI), Zeiss 100x 1.4 NA Plan-Apochromat objective, 
motorized filter wheels, fluorescein isothiocynate (FITC) and Texas Red filter sets 
(Semrock, Rochester, NY), and Slidebook 5.0 software (Intelligent Imaging Innovations, 
Denver, CO). Images were captured with 500ms exposure, identical binning, 
intensification and illumination intensity. For quantification of fluorescence intensity, 16-
bit image files were analyzed in Image J v1.41n. Background subtraction was performed 
before measurement of integrated density, and values were corrected for cell size.  
 
Image/Statistical Analysis 
Statistical significance between populations was determined by one-way ANOVA 
followed by Tukey’s Multiple Comparison post hoc analysis.  
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RESULTS 
A high-copy suppressor screen identifies Das1 as a potential suppressor of Pan1-
AID death 
 A high-copy expression library was transformed into the Pan1-AID strain and 
colonies were tested for rescue of growth of Pan1-AID in the presence of auxin. A trial 
screen was completed and one candidate gene, Das1, was validated (Figure AII.1A). 
Das1, Dst1-delta 6-Azauracil Sensitivity 1, was so named in 2012 based on its ability to 
suppress the sensitivity of Transcription Factor IIS-deficient cells to 6-Azauracil (Gomez-
Herreros et al., 2012). Das1/YJL149w was originally described as a putative F-box 
protein based on its physical association with other SCF complex members Skp1 and 
Cdc53 and its genetic interaction with Cdc34, the E2 ubiquitin-conjugating enzyme that 
functions with the SCF complex in ubiquitin-dependent proteolysis (Willems et al., 
1999). Currently, the galactose-inducted transcriptional repressor Mig2 is the only known 
target of Das1 (Lim et al., 2011).   
 All screens have the potential to find false positive candidate proteins—either 
proteins that encode the depleted protein (in this case, Pan1) or proteins that disrupt the 
nonpermissive conditions. In the high-copy suppressor screen in Pan1-AID cells, any 
protein that directly or indirectly inhibits the degradation of Pan1 will allow growth of the 
cells in the presence of auxin. To rule out these proteins, it is critical to observe the Pan1 
levels in the presence of the high-copy suppressor candidate in the presence of auxin to 
ensure Pan1 protein is depleted. Das1 is an F-box protein and might be expected to 
compete with TIR1 for binding to the SCF complex, thus potentially decreasing or 
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Figure AII.1: Das1 is a candidate high copy suppressor of Pan1-AID. 
(A) Serial dilutions of Pan1-AID cells with indicated plasmids were grown on synthetic 
media ± auxin for 3 d at 30°C. EV = empty vector. (B) Immunoblots detecting Pan1 in 
TIR1 or Pan1-AID (PA) cell lysates plus indicated plasmids grown for 4 hr ± auxin. 
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presence of high-copy Das1, Pan1-AID was still degraded to similar levels to Pan1-AID 
containing an EV plasmid after 4 hours in the presence of auxin (Figure AII.1B).  
 
High-copy Das1 does not restore endocytosis in Pan1-AID cells plus auxin 
 Das1 is an F-box protein that has no known roles in endocytosis. However, it may 
still have an indirect role in regulating the process through Pan1 and this function could 
be lost in the absence of Pan1. To determine if high-copy Das1 can restore Pan1-AID 
endocytic defects, a Mup1-pHl assay used to observe and quantify CME in the absence of 
Pan1 and presence of high-copy Das1 (Mup1-pHl assay explained in detail in Chapter 2). 
Mup1-pHl remained at the plasma membrane in presence of auxin in Pan1-AID cells 
expressing high-copy Das1, similar to empty vector plasmid (Figure AII.2). This suggests 
that Das1 was not able to rescue the endocytic arrest that occurs in the absence of Pan1. 
This indicates that Das1 does not restore growth in the absence of Pan1 by upregulating 
CME; could Das1 be functioning in Pan1’s essential pathway? More experiments will 














































Figure AII.2 High-copy Das1 does not restore endocytosis in Pan1-AID cells plus 
auxin. 
(A) Quantification of Mup1-pHl fluorescence internalized after 30 min ± auxin pre-
treatment and 1 h ± methionine in Pan1-AID cells plus indicated plasmids. Percent 
Mup1-pHl internalized was calculated by measuring the amount of fluorescence at the 
end of the assay compared to the amount at the beginning. (B) Representative images of 
Pan1-AID cells plus indicated plasmid ± pre-treatment with auxin for 30 min followed by 
addition of methionine for 1 h. Percentage is amount of Mup1-pHl internalized over 
experiment. 
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High-copy Das1 does not promote viability of pan1Δ  cells 
 Presumably, if high-copy Das1 upregulated a pathway that rescues Pan1-AID 
cells from death due to absence of Pan1, then high-copy Das1 should restore viability of 
pan1Δ cells as well. However, in a plasmid shuffle experiment high-copy Das1 did not 
rescue pan1Δ cells (Figure AII.3). This indicates that Das1 is acting as suppressor only in 
the AID background and, although Pan1 is being depleted, Das1 may be disrupting 





















Figure AII.3: High-copy Das1 does not promote the viability of pan1Δ cells. 
pan1Δ cells containing Pan1 on a uracil-selection plasmid plus indicated plasmids were 
streaked onto control (A) or 5FOA (B) plates and grown for 3 d at 30°C. EV = empty 
vector. 
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High-copy Das1 does not restore the growth of other AID strains in the presence of 
auxin  
 In order to test if Das1’s restoration of growth of Pan1-AID was specific to Pan1 
or to the AID system, it was necessary to test if Das1 could restore the growth of other 
AID-tagged strains. Qri1 is an essential protein and when tagged with AID, does not 
grow in the presence of auxin (Cunningham lab, unpublished data). Las17, while not an 
essential protein, does have a severe growth deficiency when deleted; when tagged with 
AID, the cells have a growth deficiency in the presence of auxin. High-copy Das1 did not 
restore the growth of Qri1-AID or Las17-AID (Figure AII.4). This indicates that Das1 is 
not a general high-copy suppressor of the AID system and is not competing with TIR1 to 
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Figure AII.4 High-copy Das1 does not restore growth of other AID-tagged strains.
Serial dilutions of Las17-AID and Qri1-AID cells with indicated plasmids were grown on 
synthetic media ± auxin for 3 d at 30°C. EV = empty vector. 
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DISCUSSION 
 The AID system is ideal for genetic screens because the nonpermissive conditions 
are fairly innocuous to the cells and should not induce a stress response or alter endocytic 
dynamics. In a high-copy suppressor screen of Pan1-AID, positive candidates will be 
selected for their ability to restore growth of Pan1-AID cells in the presence of auxin.  
In this system, three categories of candidate proteins should be found in the screen—
Pan1, proteins that inhibit the degradation of Pan1, and proteins that bypass the loss of 
Pan1 to restore viability through a yet unknown pathway. Candidate library plasmids 
containing Pan1 were found in the screen, which validates that the screen worked as 
expected.  
 In this small pilot screen, only one candidate protein was validated to restore 
growth and not inhibit Pan1 degradation—Das1.  Das1 is an F-box protein that one might 
expect, in theory, would compete with TIR1 for binding to the SCF complex and may 
inhibit degradation of Pan1. However, after 4 hours in the presence of auxin, in Pan1-
AID cells with high-copy Das1, Pan1 protein was degraded to levels similar to EV 
(Figure AII.1B).  
 How is Das1 restoring growth? Pan1’s main role in the cell is in CME, but high-
copy Das1 does not restore endocytosis in Pan1-AID cells (Figure AII.2). Therefore, 
Das1 may be upregulating Pan1’s unknown essential pathway. However, Das1 cannot 
restore growth of pan1Δ cells (Figure AII.3), which suggests that Das1 may require a 
trace amount of Pan1 protein that is present in the cell before it gets degraded in order to 
support viability. Is Das1 a general suppressor of the AID system? It appears not, as high-
copy Das1 cannot restore growth of two other AID-tagged strains (Figure AII.4). The 
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data in Figures AII.3 and AII.4 seem contradictory, as one would predict that if a high-
copy suppressor is not a general suppressor of the AID system, it is specific to the target 
protein and should restore viability it the delete strain. Further experiments will be 
conducted to clarify how Das1 is restoring viability and to observe the interactions 
between Pan1 and Das1. Do other F-box proteins restore viability? Preliminary results 
suggest that this rescue is specific to Das1 (data not shown). Does Das1 have an 
alternative role in the cell besides functioning as an F-box protein? Or, could Pan1’s 
essential role be in assisting Das1 in its F-box function? 
 In the future, another high-copy suppressor screen will be conducted to find 
proteins that can complement the minimal essential region, Pan1 AA402-855, to restore 
growth. This screen can be done either in the AID-background or using a plasmid-shuffle 
based assay in a pan1Δ strain. We predict that candidate proteins would include proteins 
that may interact with this region directly or bind to one of the three flanking essential 
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